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FANCM AND FAAP24 MAINTAIN GENOMIC STABILITY THROUGH
COOPERATIVE AND UNIQUE FUNCTIONS

Publication No. ________
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Supervisory Professor: Lei Li, Ph.D.

Fanconi anemia (FA) is a rare recessive genetic disease with an array of clinical
manifestations including multiple congenital abnormalities, progressive bone marrow failure
and profound cancer susceptibility. A hallmark of cells derived from FA patients is
hypersensitivity to DNA interstrand crosslinking agents such as mitomycin C (MMC) and
cisplatin, suggesting that FA- and FA-associated proteins play important roles in protecting
cells from DNA interstrand crosslink (ICL) damage. Two genes involved in the FA
pathway, FANCM and FAAP24, are of particular interest because they contain DNA
interacting domains. However, there are no definitive patient mutations for these two genes,
and the resulting lack of human genetic model system renders their functional studies
difficult.
In this study, I established isogenic human FANCM- and FAAP24-null mutants
through homologous replacement-mediated gene targeting in HCT-116 cells, and
systematically investigated the functions of FANCM and FAAP24 in chromosome stability,
FA pathway activation, DNA damage checkpoint signaling, and ICL repair. I found that the
FANCM-/-/FAAP24-/- double mutant was much more sensitive to DNA crosslinking agents
than FANCM-/- and FAAP24-/- single mutants, suggesting that FANCM and FAAP24 possess
vi

epistatic as well as unique functions in response to ICL damage. I demonstrated that FANCM
and FAAP24 coordinately support the activation of FA pathway by promoting chromatin
localization of FA core complex and FANCD2 monoubiqutination. They also cooperatively
function to suppress sister chromatid exchange and radial chromosome formation, likely by
limiting crossovers in recombination repair. In addition, I defined novel non-overlapping
functions of FANCM and FAAP24 in response to ICL damage. FAAP24 plays a major role
in activating ICL-induced ATR-dependent checkpoint, which is independent of its interaction
with FANCM. On the other hand, FANCM promotes recombination-independent ICL repair
independently of FAAP24. Mechanistically, FANCM facilitates recruitment of nucleotide
excision repair machinery and lesion bypass factors to ICL damage sites through its
translocase activity. Collectively, my studies provide mechanistic insights into how genome
integrity is both coordinately and independently protected by FANCM and FAAP24.
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CHAPTER I
Background and Significance

Fanconi anemia
Fanconi anemia (FA) is a rare genetic disease first described in 1927 by a Swiss
physician Guido Fanconi. The main clinical features of FA are multiple developmental
abnormalities, progressive bone marrow failure, and remarkably increased risks for
developing cancer (Moldovan and D'Andrea, 2009). The most frequent congenital defects
among FA patients include short stature, skeletal defects and skin abnormalities, although a
wide range of organ systems can be affected (D'Andrea, 2010). FA patients typically develop
bone marrow failure within their first decade of life (Alter et al., 2003), which eventually
leads to pancytopenia. By the age of 40, the cumulative risk of bone marrow failure is up to
90% (Kutler et al., 2003). The most common hematological and non-hematological
malignancies seen in FA patients are acute myelogenous leukemia (AML) and squamous cell
carcinomas of the head and neck, respectively (Kitao and Takata, 2011). Clinically, Fanconi
anemia is a highly devastating disease. Even with bone marrow transplantation and advanced
medical care, the median age at death was only 30 by the year 2000 (D'Andrea, 2010).
At the cellular level, Fanconi anemia is characterized by hypersensitivity to DNA
interstrand crosslinking agents such as diepoxybutane (DEB), mitomycin C (MMC), and
cisplatin (German et al., 1987; Poll et al., 1985). When exposed to DEB, cells from FA
patients display increased chromosome breakage and accumulation in the G2 phase of cell
cycle (D'Andrea, 2010). The DEB-induced chromosome-breakage assay is actually widely
used for the diagnosis of Fanconi anemia using patient primary lymphocytes (Auerbach,
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1993; D'Andrea, 2010).
Fanconi anemia genes
Fanconi anemia is a highly heterogeneous disorder with at least fifteen
complementation groups defined to date, each caused by mutation(s) of a distinct gene. Most
of the FA genes were identified through cell fusion experiments and are organized into
complementation groups. (Crossan and Patel, 2012). Newer FA genes were discovered
primarily through positional cloning, functional RNAi screen, or genome sequencing (Kim et
al., 2011; Levitus et al., 2005; Litman et al., 2005; Meetei et al., 2003; Meetei et al., 2005;
Reid et al., 2007; Smogorzewska et al., 2007; Stoepker et al., 2011; Vaz et al., 2010; Xia et
al., 2007). The fifteen FA genes defined to date are listed in Table 1. Most of the FA genes
are located on autosomes, with only one exception FANCB, which lies on the X chromosome.
Therefore, the inheritance of Fanconi anemia is in either autosomal recessive or X-linked
recessive manners. The most frequently mutated genes in Fanconi anemia are FANCA,
FANCC, and FANCG, accounting for ~66%, ~10% and ~9% of the FA patients, respectively
(Moldovan and D'Andrea, 2009; Wang, 2007).
A number of genes are functionally related to and/or physically associated with FA
genes. The products of such genes are therefore termed as FA-associated proteins. These
include FAAP100, FAAP24, FAN1, MHF1 (FAAP16), MHF2 (FAAP10) and FAAP20 (Ali
et al., 2012; Ciccia et al., 2007; Kim et al., 2012; Kratz et al., 2010; Leung et al., 2012; Ling
et al., 2007; Liu et al., 2010; MacKay et al., 2010; Singh et al., 2010; Smogorzewska et al.,
2010; Yan et al., 2010; Yan et al., 2012). To date, no loss of function mutations of the above
genes have been found in FA patients.
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Table 1.1 Fanconi anemia genes identified to date.
FA gene

Chromosome
location
16q24.3

Protein
size
(kDa)
163

FANCA

Function in FA
pathway
Core complex

FANCB

Xp22.2

95

Core complex

FANCC
FANCD1/
BRCA2

9q22.3
13q12.3

63
380

Core complex
Homologous
recombination

FANCD2

3p26

155

ID complex

FANCE

6p22-p21

60

Core complex

FANCF
FANCG

11p15
9p13

42
68

Core complex
Core complex

FANCI

15q26.1

140

ID complex

FANCJ/
BRIP1

17q22.2

140

Homologous
recombination

FANCL

2p16.1

43

Core complex

FANCM

14q21.2

250

Core complex

FANCN/
PALB2
FANCO/
RAD51C
FANCP/
SLX4

16p12.2

140

Protein features

Phosphorylated following DNA
damage
Contains nuclear localization
sequence
Contains BRC repeats and an OB‑
fold DNA binding domain; regulates
RAD51
Monoubiquitylated and
phosphorylated following DNA
damage; exonuclease activity
Phosphorylated by Chk1 following
DNA damage
Contains TPR repeats;
phosphorylated following DNA
damage
Monoubiquitylated and
phosphorylated following DNA
damage
5’ to 3’ DNA helicase; binds
BRCA1; phosphorylated following
DNA damage; G-quadruplex
resolution
PHD/ring-finger ubiquitin-ligase
activity; contains WD40 repeats
Contains helicase and endonuclease
domains; phosphorylated following
DNA damage
An essential partner for BRCA2
stability and nuclear localization
RAD51 paralogue

Homologous
recombination
17q25.1
42
Homologous
recombination
16p13.3
200
Nucleolytic
Interacts with structure-specific
cleavage /
endonuclease complexes; Holliday
Homologous
junction resolvase
recombination
Adapted (with permission) from Wang, 2007 and Crossan and Patel, 2012.
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Fanconi anemia pathway
The fact that cells from FA patients are hypersensitive to DNA cross-linking agents
suggests that genes mutated in Fanconi anemia play important roles in DNA damage
response and repair. Indeed, accumulating evidences suggest that FA and FA-associated
proteins constitute a FA pathway which is important in protecting cells from DNA
interstrand crosslink (ICL) lesions and maintaining genomic stability (Fig 1.1).
Eight of the FA proteins FANCA, B, C, E, F, G, L, and M, together with five FAassociated proteins (FAAP100, FAAP24, MHF1, MHF2 and FAAP20), form a FA core
complex (Ali et al., 2012; Ciccia et al., 2007; Kim et al., 2012; Leung et al., 2012; Ling et al.,
2007; Singh et al., 2010; Yan et al., 2010; Yan et al., 2012). In response to DNA damage, the
FA core complex monoubiquitinates a heterodimeric ID complex composed of FANCD2 and
FANCI (Meetei et al., 2004; Smogorzewska et al., 2007; Wang, 2007). Central to the FA
pathway, this monoubiquitination reaction triggers the recruitment of the FANCD2associated nuclease FAN1 and the FANCP gene product SLX4, a scaffolding protein
involved in assembly of structure-specific nucleases (Crossan et al., 2011; Kratz et al., 2010;
Liu et al., 2010; MacKay et al., 2010; Smogorzewska et al., 2010; Stoepker et al., 2011),
followed by ICL processing by multiple nucleases. Four other FA proteins BRCA2/FANCD1,
BRIP1/FANCJ, PALB2/FANCN, and Rad51C/FANCO, also known as breast cancer
susceptibility proteins (Howlett et al., 2002; Levitus et al., 2005; Reid et al., 2007; Vaz et al.,
2010; Wang, 2007; Xia et al., 2007), are mainly associated with downstream homologous
recombination (HR)-mediated repair of DNA double strand breaks formed as a result of ICL
processing (Shen et al., 2009).
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Fig. 1.1 The Fanconi anemia pathway.
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FANCM and FAAP24
How the FA pathway acts to protect cells from DNA interstrand crosslink (ICL)
lesions and to maintain genomic stability remains largely unclear. Further understanding of
this pathway has been restricted, partially because most of the FA proteins are only
conserved in vertebrates and lack well known functional domains (Wang, 2007).
Among the FA core complex components, FANCM is of particular interest. It was
initially identified as a novel component (FAAP250) of the FA core complex during tandem
affinity purification of FANCA. The gene encoding FAAP250 was later found to be mutated
in one Fanconi anemia patient that needed to be classified into a new complementation group
(M), and therefore the gene was named as FANCM (Meetei et al., 2005). Structurally, human
FANCM resembles archaeal DNA repair protein Hef and eukaryote endonuclease XPF. It
contains a DEAH helicase domain at its N-terminus as well as an ERCC4-like endonuclease
domain at the C-terminus (Meetei et al., 2005). Translocase activity, instead of helicase
activity, was found to be associated with the helicase domain. The endonuclease domain is
degenerated and thus no nucleolytic activity was found in FANCM (Meetei et al., 2005).
Given that the flap-specific endonuclease family typically forms heterodimers such as
XPF/ERCC1 and Mus81/Eme1, a bioinfomatics study was conducted to search for FANCM
binding partner. A novel protein with ERCC4-like endonuclease domain was identified as a
potential new XPF family member. It was then found to specifically interact with FANCM
and to be an intrinsic component of the FA core complex, and was later named as FAAP24
(Ciccia et al., 2007).
FANCM and FAAP24 promote FA pathway activation

7

Being an integral component of the FA core complex, FANCM was initially thought
to be required for the stability of the core complex and monoubiquitylation of FANCD2. This
was supported by the fact that in the potential FANCM patient-derived cell line (EUFA867),
levels of FANCA and FANCG were reduced, and FANCD2 monoubiquitylation was
completely absent (Meetei et al., 2005). However, siRNA mediated depletion of FANCM did
not lead to significant decrease of FANCA and FANCG levels or disruption of
FANCA/FANCG/FANCL association in HeLa cells, arguing against the necessity of
FANCM in maintaining FA core complex integrity (Kim et al., 2008). This discrepancy was
not resolved until identification of biallelic FANCA mutations in EUFA867 cells (Singh et al.,
2009), suggesting that FANCA and FANCG defects in EUFA867 cells are due to FANCA
mutations, and FANCM may not be required for maintaining the integrity of the core
complex. Importantly, re-expression of FANCA in EUFA867 lymphoblasts only partially
restored FANCD2 monoubiquitylation, suggesting that FANCM promotes FANCD2
monoubiquitylation although it is not indispensable for this process (Singh et al., 2009). This
finding was consistent with subsequent genetic studies in mouse models as well as chicken
DT40 cells (Bakker et al., 2009; Rosado et al., 2009).
The fact that FANCM is not essential for FA core complex integrity or FANCD2
monoubiquitylation distinguishes it from earlier identified FA core complex proteins. It is
likely that FANCA, B, C, E, F, G, L, FAAP100 and FAAP20 first form a sub-complex, while
FANCM/FAAP24 heterodimer interacts with and targets this subcomplex to chromatin
where they form the larger active core complex (Thompson and Hinz, 2009). This appears to
be an attractive model, since FANCM and FAAP24 possess DNA-binding domains and
activities. FANCM has a DEAH-helicase domain at the N-terminus, and both FANCM and
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FAAP24 have ERCC4-like endonuclease domains at their C-termini (Ciccia et al., 2007).
FANCM was shown to have translocase activity in vitro, making it a plausible candidate
damage sensor that moves along DNA to detect replication fork blockage or other types of
abnormal structures (Meetei et al., 2005). In vitro assays demonstrated that FAAP24 could
bind to ssDNA, splayed-arm, and 3’-flap DNA substrates, and while FANCM 1727-2048 alone
exhibits very little DNA binding activity, FANCM 1727-2048 /FAAP24 complex binds to a
variety of substrates with a preference to splayed-arm DNA, suggesting that FAAP24 may
play an important role in facilitating damage recognition and binding by the
FANCM/FAAP24 heterodimer (Ciccia et al., 2007). It is possible that following detection of
DNA damage such as replication fork blockage by ICL, this heterodimer would target FA
core complex to chromatin. Indeed, in vivo studies demonstrated that FANCM constitutively
associates with chromatin and is tethered to the latter by FAAP24 as an anchor, and the
FANCM/FAAP24 heterodimer is required for chromatin association of the FA core complex
during S phase and in response to DNA damage (Kim et al., 2008). It is likely that FANCM
and FAAP24 do not significantly affect the E3 ligase activity of the core complex, but rather
its availability for substrate binding.
Another two FANCM-associated proteins, MHF1 and MHF2, have been identified
via their co-purification with FANCM (Singh et al., 2010; Yan et al., 2010). The MHF
proteins also possess DNA binding activity, and they can promote the DNA interacting
activities of FANCM (Yan et al., 2010). Importantly, they have been shown to act together
with FANCM to activate the FA pathway (Singh et al., 2010; Yan et al., 2010). Therefore, it
appears that FANCM, FAAP24 and the MHF proteins coordinately activate the FA pathway
by recruiting the FA core complex upon DNA damage recognition.
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FANCM and FAAP24 in DNA damage checkpoint activation
FANCM and FAAP24 are implicated in the activation of ATR-mediated checkpoint
by several groups. It was shown that FANCM and FAAP24 interact with the ATR-ATRIPHCLK2 complex, and depletion of FANCM or FAAP24 leads to defective ATR/Chk1
signaling, manifesting as increased spontaneous S phase DNA damage, diminished foci
formation of phosphorylated Chk1 and other substrates, and failure to prevent mitotic entry
in response to replication stress (Collis et al., 2008; Luke-Glaser et al., 2009; Schwab et al.,
2010). Mechanistically, FANCM has been shown to retain TopBP1 on chromatin in response
to replication stress, which is important for ATR activation (Schwab et al., 2010). It was also
suggested that FANCM and Chk1 mutually stabilize each other, thus sustaining necessary
checkpoint signaling in response to DNA damage (Luke-Glaser et al., 2009). In addition, the
function of FANCM in ATR/Chk1 signaling requires its translocase activity, suggesting that
the putative replication fork remodeling activity of FANCM may be important for efficient
checkpoint activation (Collis et al., 2008).
A recent study suggests that the potential function of FANCM and FAAP24 in ATRmediated checkpoint activation appears to be specifically linked to ICL damage response
(Huang et al., 2010). It was shown that cells lacking FANCM or FAAP24 are deficient in
RPA foci assembly in response to ICL damage but not to replication stress induced by
hydroxyurea. This leads to an ICL damage specific ATR-mediated checkpoint defect.
Furthermore, the DNA binding activity of FAAP24 but not the translocase activity of
FANCM is important for their function in ICL-induced activation of ATR-mediated
checkpoint (Huang et al., 2010). Given the apparent discrepancies in data obtained from
different studies, further studies are warranted to elucidate the role of FANCM and FAAP24
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in DNA damage checkpoint activation.
FANCM remodels stalled replication fork
In FANCM deficient cells, expression of a K117R translocase mutant of FANCM
could restore FANCD2 monoubiquitylation but could not fully correct MMC sensitivity (Xue
et al., 2008). This suggests that the translocase activity allows FANCM to function in parallel
to or downstream of FANCD2 monoubiquitylation to promote or directly mediate ICL repair.
FANCM was observed to promote branch migration of Holliday junctions and
replication forks in vitro (Gari et al., 2008b), suggesting that FANCM either functions to
facilitate Holliday junction branch migration during homologous recombination or to regress
stalled replication forks to facilitate ICL repair. Given that FANCM was dispensable for the
repair of I-SceI induced double strand breaks (DSBs) by homologous recombination in DT40
cells (Mosedale et al., 2005), it is more likely that FANCM remodels the structure of stalled
replication forks in response to replication stress. Indeed, in vitro studies demonstrated that
FANCM has the ability to convert a replication-fork structure to a four-way junction, causing
a replication fork regression (Gari et al., 2008a). In addition, in vivo studies demonstrated
that in the absence of FANCM, the progression of replication forks are unstable in both
mammalian cells and chicken DT40 cells, suggesting that FANCM is critical for the control
of replication fork movement (Luke-Glaser et al., 2009; Schwab et al., 2010). Importantly,
the translocase activity of FANCM is required for recovery of stalled replication forks
(Blackford et al., 2012; Luke-Glaser et al., 2009; Schwab et al., 2010), indicative of a role of
FANCM in remodeling replication forks in response to replication stress. Consistently, cells
lacking FANCM are hypersensitive to agents that inhibit replication fork progression such as
camptothecin, hydroxyurea and aphidicolin (Schwab et al., 2010; Singh et al., 2009).
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FANCM limits crossovers and suppresses sister chromatid exchange
Yeast orthologs of FANCM, namely Fml1 in S. Pombe and Mph1 in S. cerevisiae,
limit crossovers during homologous recombination by dissociating Rad51-induced D-loops,
thereby suppressing sister chromatid exchanges (SCEs) (Prakash et al., 2009; Sun et al.,
2008). Chicken DT40 cell depleted of FANCM and Fancm-/- MEFs both displayed increased
basal SCE levels as well (Bakker et al., 2009; Mosedale et al., 2005; Rosado et al., 2009).
Consistently, human cells deficient for FANCM also showed increased SCE formation both
at basal level and after MMC treatment (Deans and West, 2009).
How FANCM functions to suppress SCE is not fully understood. A recent study
demonstrated that FANCM connects the FA core complex and the Bloom’s complex through
direct interaction with FANCF and RMI1, respectively, and the coordinated recruitment of
both complexes are important for SCE suppression (Deans and West, 2009). However, while
the BLM helicase is well known for its function in SCE suppression, whether FA core
complex is required for suppressing SCE remains controversial (Bakker et al., 2009; Rosado
et al., 2009). Therefore, alternative mechanisms of FANCM’s function in SCE suppression
need to be explored.
In the absence of FANCM, insufficient replication fork regression and stabilization in
response to replication stress will result in increased DSB formation due to fork collapse, the
repair of which may result in SCEs (Bakker et al., 2009). In addition, like its yeast orthologs,
recombinant FANCM protein is capable of dissociating D-loop structures in vitro (Gari et al.,
2008a). Furthermore, FANCM orthologs in fission yeast and plants have been shown to be
important for limiting crossovers during meiosis (Crismani et al., 2012; Knoll et al., 2012;
Lorenz et al., 2012). Collectively, it is therefore possible that human FANCM plays an
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important role in limiting crossover and suppressing SCE formation via direct enzymatic
activities.
Posttranslational regulation of FANCM
Given the multiple roles FANCM plays in DNA damage response and repair, it would
be important to understand the regulation mechanisms of FANCM function. FANCM is a
phosphoprotein that becomes hyperphosphorylated in response to DNA damage, and this
phosphorylation is independent of the FA core complex (Meetei et al., 2005). In addition,
FANCM phosphorylation is dynamically regulated throughout cell cycle, with moderate and
extensive phosphorylation during S phase and mitosis respectively while dephosphorylated
after

mitotic

exit.

This

dynamic

change

negatively

correlates

with

FANCD2

monoubiquitylation level and FA core complex-chromatin association, suggesting that
FANCM phorsphorylation regulates the FA pathway (Kim et al., 2008). Further studies
demonstrated that the Plk1 kinase is responsible for FANCM phorsphorylation during
mitosis, and FANCM phorsphorylation is followed by its degradation mediated by the βTRCP component of the SCF E3 ligase, which may be important for releasing the FA core
complex and inactivation of DNA repair machinery (Kee et al., 2009). In xenopus, FANCM
phosphorylation is shown to be under control of ATR and ATM, and more interestingly,
FANCD2, but whether this is also true for human proteins needs to be addressed.
Genetic models for FANCM
An avian cellular model for FANCM was constructed in DT40 lymphoblastoid
platform. DT40 cells lacking FANCM display sensitivity to ICL damage, camptothecin and
UV light (Rosado et al., 2009). Interestingly, UV sensitivity of human cells deficient for
FANCM has also been reported, suggesting that FANCM has functions related to the repair
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of UV lesions (Kelsall et al., 2012). A mutation in the translocase domain of avian FANCM
does not affect FA pathway activation but impairs SCE suppression (Rosado et al., 2009),
suggesting the enzymatic activity of FANCM is indeed important for suppressing SCE.
A mouse model for FANCM has also been generated (Bakker et al., 2009). Fancm-/mice show gonadal anomalies, increased tumor formation (lymphoma, histiocytic sarcoma,
hepatoma, lung cancer) and reduced life span. Fancm-/- MEF cells display ICL damage
sensitivity, increased chromosome breakage, excessive G2 arrest, deficient FA pathway
activation and increased SCE formation (Bakker et al., 2009). Although Fancm-/- MEF cells
recapitulate typical FA cellular characteristics, the FANCM mouse model, as well as other
FA mouse models, does not fully phenocopy FA clinical features, especially in terms of
hematological pathology (Bakker et al., 2009; Parmar et al., 2009).
Since no genuine FANCM patient is available, an effective human genetic model for
FANCM is lacking. On the other hand, genetic models for FAAP24 are unavailable.
Generation of human cellular knockout mutants will therefore be important for further
functional studies of FANCM and FAAP24.

In this dissertation, I constructed FANCM-/-, FAAP24-/-, and FANCM-/-/FAAP24-/human somatic knockout cell lines, and systematically investigated the function of FANCM
and FAAP24 in chromosome stability, FA pathway, DNA damage checkpoint, and ICL
repair. I found that FANCM and FAAP24 are not fully epistatic in response to ICL damage.
Specifically, while FANCM and FAAP24 coordinately activate FA pathway and suppress
SCE, they also possess non-overlapping functions - FANCM promotes recombinationindependent ICL repair, and FAAP24 facilitates efficient ATR-mediated checkpoint
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activation in response to ICL damage. These genetic evidences support a model that FANCM
and FAAP24 have cooperative as well as unique functions in maintaining genomic stability.
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CHAPTER II
Generation of FANCM and FAAP24 somatic knockout cell lines

Introduction
Fanconi anemia (FA) is a rare recessive genetic disorder characterized by multiple
developmental abnormalities, progressive bone marrow failure, and profoundly increased
cancer susceptibility (Moldovan and D'Andrea, 2009). The genetic complexity of Fanconi
anemia is remarkably high, with at least fifteen complementation groups identified to date,
each caused by mutation(s) of a distinct gene. A hallmark of cells derived from FA patients is
hypersensitivity to DNA interstrand crosslinking agents such mitomycin C (MMC) and
cisplatin (German et al., 1987; Poll et al., 1985), suggesting that FA genes play important
roles in DNA damage response and repair.
Accumulating evidences support that FA and FA-associated proteins constitute the
Fanconi anemia pathway, which is important for repair of DNA interstrand crosslink (ICL)
lesions and maintenance of genomic stability. In response to DNA damage, two groups of FA
and FA-associated proteins coordinately execute a monoubiquitination reaction. Eight FA
proteins (FANCA, B, C, E, F, G, L and M), together with three FA-associated proteins
(FAAP100, FAAP24 and FAAP20) and two FANCM associated histone-fold proteins
(MHF1 and MHF2), form a FA core complex (Ciccia et al., 2007; Ling et al., 2007). This
complex functions as an E3 ligase, and monoubiquitinates a heterodimeric ID complex
consisting of FANCD2 and FANCI (Meetei et al., 2004; Smogorzewska et al., 2007; Wang,
2007) upon DNA damage. This monoubiquitination reaction is the central event of FA
pathway activation, and it triggers the recruitment of the FANCD2-associated nuclease
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FAN1 and the FANCP gene product SLX4, a scaffolding protein involved in a structurespecific nuclease complex (Crossan et al., 2011; Kratz et al., 2010; Liu et al., 2010; MacKay
et al., 2010; Smogorzewska et al., 2010; Stoepker et al., 2011). The multiple nucleases
recruited to the damage sites are important for lesion incision and therefore ICL repair. Four
other

FA

proteins

BRCA2/FANCD1,

BRIP1/FANCJ,

PALB2/FANCN,

and

Rad51C/FANCO, also known as breast cancer susceptibility proteins (Howlett et al., 2002;
Levitus et al., 2005; Vaz et al., 2010; Wang, 2007; Xia et al., 2007), do not seem to be
directly regulated by the FA core complex or involved in the ID complex monoubiquitination.
Given their defined roles in homologous recombination (HR)-mediated repair, this group of
FA proteins likely functions to repair DNA double strand breaks formed as a result of ICL
processing and to reestablish collapsed replication forks.
FANCM is of particular interest among the FA core complex components. It contains
a DEAH helicase domain and associated ATP-dependent DNA translocase activity, and also
an ERCC4-like endonuclease domain albeit degenerate (Ciccia et al., 2007; Hoadley et al.,
2012; Meetei et al., 2005). FANCM closely associates with a binding partner FAAP24 as
well as the MHF1/MHF2 histone-fold complex, and cooperatively they bind to and
stabilize/remodel stalled replication forks (Gari et al., 2008a; Gari et al., 2008b; Yan et al.,
2010). The FANCM/FAAP24 complex constitutively associates with chromatin, and upon
recognition of replication-fork blocking lesions, it targets the FA core complex to DNA
damage sites to monoubiquitinate the ID complex (Kim et al., 2008). At the stalled
replication fork, FANCM also coordinates FA pathway activation with other DNA damage
responsive events (Kee and D'Andrea, 2010), including ATR-mediated checkpoint activation
(Collis et al., 2008; Huang et al., 2010; Schwab et al., 2010), and recruitment of Bloom’s
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complex which is important for suppression of sister chromatid exchange (SCE) formation
(Deans and West, 2009).
While FANCM and FAAP24 have been suggested to play multiple roles in
mammalian DNA damage response and repair, most of the supporting evidences were
obtained from si-RNA based studies. The lack of genetic evidences resulted from the
unavailability of ideal human genetic models for FANCM and FAAP24. The only FANCM
patient reported to date also harbors bi-allelic mutations of FANCA (Singh et al., 2009),
making the true classification of this patient controversial. On the other hand, FAAP24
mutations have not been found yet in Fanconi anemia patients. Such a lack of genetic model
system restricts substantiation of the functions of FANCM and FAAP24 in FA pathway
activation, DNA damage checkpoint signaling, and suppression of crossover recombination.
It also prevents in-depth studies of how these potential functions integrate together to
maintain genomic stability. In addition, the lack of an isogenic cellular model system
precludes epistatic analysis between FANCM and FAAP24, and renders exploration of
additional functions of these two proteins difficult.
To precisely determine the functional significance of FANCM and FAAP24 in
genomic integrity maintenance, I sought to establish isogenic human FANCM- and FAAP24null mutants through homologous replacement targeting in HCT-116 cells. In this chapter, I
describe the generation of FANCM-/-, FAAP24-/-, and FANCM-/-/FAAP24-/- somatic knockout
cell lines. This genetic model system will readily allow functional characterization of
FANCM and FAAP24 in DNA damage response and repair, and epistatic analysis between
these two proteins, which will be described in following chapters.
Materials and Methods
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Cell culture
Human colorectal carcinoma HCT-116 and human embryonic kidney 293T
(HEK293T) cell lines were obtained from the American Type Culture Collection (ATCC).
Wild type HCT-116, its somatic knockout derivatives, and HEK293T cells were all
maintained in Dulbecco's Modification of Eagles Medium (DMEM) plus 10% fetal calf
serum (FBS) and grown in a humidified 5% CO 2 -containing atmosphere at 37°C.
Targeting construct
FANCM and FAAP24 targeting vectors were constructed using the USER cloning
technology (New England BioLabs). Briefly, ~1.5 kb homology arms were PCR amplified
from HCT-116 genomic DNA, using the following primers (upper case letters indicate USER
cloning sites, and lower case letters indicate specific genomic sequences):
FANCM Left arm forward: GGGAAAGUcacgttcacttccctttaaacaat
FANCM Left arm reverse: GGAGACAUcaaagctggcacttatctaggact
FANCM Right arm forward: GGTCCCAUttggggactgtaaacgttattgta
FANCM Right arm reverse: GGCATAGUgccagcatacctgtaatgtagtga
FAAP24 Left arm forward: GGGAAAGUgactcatcagcagatctatccaca
FAAP24 Left arm reverse: GGAGACAUggatgaaaagatggcaataatagg
FAAP24 Right arm forward: GGTCCCAUcgtatttttgttaagcatcagcac
FAAP24 Right arm reverse: GGCATAGUtcagcttgacttaagggaacaaat
The amplified homology arms were cloned into the pAAV-USER vector to flank a
neomycin resistance gene (neo) cassette (Fig 2.1). The pAAV-USER vector differs from the
originally described AAV-USER-3×FLAG-KI vector (Zhang et al., 2008) in that the triple
FLAG tag has been removed.
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rAAV-mediated gene targeting
The targeting vector was co-transfected into HEK293T cells together with pAAV-RC
and pHelper plasmids, and the virus produced was collected 72 hours post transfection by
lysing cells with three cycles of freeze and thaw (each cycle consisted of 10 min freeze in a
dry ice-ethanol bath, and 10 min thaw in a 37 °C water bath). The supernatants containing the
rAAV virus was used to infect HCT-116 cells. After 48 hours of virus infection, cells were
plated out in low density in G418 containing media to allow growth of G418-resistant
colonies.
PCR screening
G418-resistant colonies were screened for desired gene targeting events using a PCR
strategy (Fig 2.2). Genomic DNA was extracted using the Lyse and Go PCR Reagent
(Thermo Scientific), and PCR was conducted using the following primers:
FMScrL1: aagccgcactcaggatgccacttgc
FMScrR3: ttccattgtctgggccacagttcagc
F24ScrL3: ttctcttgtgccgcccccttgactg
F24ScrR1: ggcatggatctgctgtgccactgctt
neoS2: gcggcatcagagcagccgattgtct
3F1: gcgcatcgccttctatcgccttcttg
The neo cassettes in positively-targeted clones were excised by infecting the cells
with Ade-Cre virus. After 24 hours of virus infection, cells were plated out in low density,
and the colonies grown out were screened by PCR (Fig 2.3) to confirm the excision of neo
cassette. The primers used were as follows:
FMLCreL: gcgtataccccatgggtaact
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FMRCreR: agctgtcagggctgtctggtt
F24ScrL2: gtcacagctggcgcaggagatgcaa
F24ScrR3: tccccatgctgggatcagaggcgta
The heterozygous clones were infected with the rAAV virus again to target the
second allele, and the neo cassettes were again removed from positively-targeted null clones.
Disruption of both wild type alleles were confirmed by PCR (Fig 2.3) using the following
primers:
FMUpStrm: ctcaggatgccacttgctgatg
FME2R: ccttcctggtggaagcttgtgt
FME2F: tggtgcagtaagagagtgcttt
FMI2R: ctatggcctacaaaggctttca
F24UpStrm: gccccaacactttacccctaa
F24E3R: tttcctgccaccaaatcagctt
F24E3F: gatggcttgacaccagactttt
F24E4R: attccaaggtccagcacagtaa
Western blot
Whole cell lysates were prepared by lysing cells with NETN-SDS buffer (20 mM
Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40, 0.5% deoxycholate, 0.5%
SDS) followed by brief sonication. Western blot was performed following standard protocol.
Briefly, protein samples were mixed with 2×SDS buffer, boiled, separated with SDS-PAGE,
and electrotransfered onto nitrocellulose membranes, and immunoblot was carried out with
primary antibodies as indicated. After washing for three times, the membrane was incubated
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with secondary anti-rabbit or anti-mouse antibody conjugated with horseradish peroxidase.
The blot was developed with enhanced chemiluminescence reagent (Amersham Biosciences).
Antibodies
Polyclonal antibodies against FAAP24 were raised in rabbits by using MBP-tagged
full length FAAP24 protein as the antigen and affinity-purified with GST-FAAP24 fusion
protein. Polyclonal rabbit antibodies against FANCM1190-1273 were similarly raised and
purified. FANCB antibody was described previously (Meetei et al., 2005). Sources of
commercial antibodies are as follows: anti-β-actin (sc-69879, Santa Cruz); peroxidaseconjugated rabbit anti-mouse (315-035-048, Jackson ImmunoResearch); peroxidaseconjugated goat anti-rabbit (111-035-144, Jackson ImmunoResearch); and horseradish
peroxidase (HRP)-conjugated protein A (NA-9120V, GE Healthcare).
Results
Strategy for FANCM and FAAP24 loci targeting
To establish human genetic models for FANCM and FAAP24, homologous
replacement-mediated gene targeting was performed in HCT-116 cells. Recombinant adenoassociated virus (rAAV) was used to deliver targeting vectors, which contained ~1.5 kb
homology arms flanking a neomycin resistance gene (neo) cassette (Fig 2.1). Through gene
targeting, exon 2 of FANCM was disrupted, leading to a frame-shift mutation and premature
termination in exon 3 (Fig 2.1A). Similarly, exons 3 and 4 of FAAP24 were ablated, resulting
in a frame-shift mutation (Fig 2.1B). Sequential targeting was performed so that both alleles
were inactivated, thereby generating the FANCM-/- and FAAP24-/- knockout cell lines. A
FANCM-/-/FAAP24-/- double knockout cell line was also generated by targeting FAAP24 in
the FANCM-/- knockout cells.
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Fig. 2.1 Homologous replacement mediated targeting of FANCM and FAAP24 loci in HCT116 cell line.
(A) Schematics of FANCM targeting strategy.
(B) Schematics of FAAP24 targeting strategy.
Numbered boxes indicate relative locations of exons. HA: homology arm; TK: thymidine
kinase gene promoter; Neo: neomycin resistance gene cassette; L(R)-ITR: left (right)
inverted tandem repeats.
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Generation of heterozygous FANCM+/- and FAAP24+/- cell lines
HCT-116 cells were infected with rAAV virus containing FANCM or FAAP24
targeting vector, and G418-resistant clones were screened for correct targeting events using
PCR. Each pair of screening primer includes one primer located outside of the homology arm
and the other located within the neo cassette. For FANCM targeting, I screened ~200 G418resistant colonies, and identified 4 positive (+/n) clones with correct targeting. For FAAP24
targeting, 3 out of the ~400 colonies screened were positive for correct targeting. All +/n
clones were expanded and confirmed by PCR using primers spanning both homology arms
(Fig 2.2).
In order to remove the neo cassette, the +/n clones were exposed to Ad-Cre virus, and
plated out in low density. The resulted cell colonies were screened by PCR to confirm the
loss of neo cassette. Due to the high titer of virus used, most of the colonies screened were
verified to be heterozygous FANCM+/- or FAAP24+/- clones (data not shown).
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Fig. 2.2 Identification of FANCM+/n and FAAP24+/n clones.
(A) PCR screening strategy for FANCM+/n clone identification. HA: homology arm; TK:
thymidine kinase gene promoter; Neo: neomycin resistance gene cassette.
(B) Confirmative PCR of the targeted allele in four FANCM+/n clones using both left arm
(FMScrL1/neoS2) and right arm (3F1/FMScrR3) primers.
(C) PCR screening strategy for FAAP24+/n clone identification. HA: homology arm; TK:
thymidine kinase gene promoter; Neo: neomycin resistance gene cassette.
(D) Confirmative PCR of the targeted allele in three FAAP24+/n clones using both left arm
(F24ScrL3/neoS2) and right arm (3F1/F24ScrR1) primers.
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Generation of FANCM-/- and FAAP24-/- somatic knockout cell lines
In order to generate the FANCM-/- and FAAP24-/- somatic knockout cell lines, one
heterozygous clone for each gene was used for second allele targeting. The FANCM+/- and
FAAP24+/- cells were infected with rAAV virus containing corresponding targeting vector,
and G418-resistant clones were again screened by PCR to identify correct targeting events.
Since both the knockout allele and the remaining wild type allele may be targeted at equal
frequencies, the positive clones were also screened for the presence of knockout allele as
well as absence of wild type allele (Fig 2.3A & Fig 2.4A). For FANCM targeting, I screened
~700 G418-resistant colonies, and identified one positive (-/n) clone with correct targeting of
the remaining wild type allele. For FAAP24 targeting, one out of the ~1200 colonies screened
was positive for correct targeting of the remaining wild type allele. The FANCM-/n and
FAAP24-/n clones were expanded and confirmed by PCR for the presence of targeted allele
and knockout allele, as well as the absence of wild type allele (Fig 2.3B & Fig 2.4B).
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Fig. 2.3 Identification of the FANCM-/- clone.
(A) PCR screening strategy for FANCM-/n and FANCM-/- clone identification. HA: homology
arm; Neo: neomycin resistance gene cassette.
(B) PCR genotyping of the FANCM-/n clones and FANCM-/- clones. +: wild type allele; n:
targeted allele; -: knockout allele.
(a) PCR of targeted allele using left arm primers (FMScrL1/neoS2).
(b) PCR of knockout allele using FMLCreL/FMRCreR primers.
(c) PCR of wild type allele using FMUpStrm/FME2R primers.
(d) PCR of wild type allele using FME2F/FMI2R primers.

29

30

Fig. 2.4 Identification of the FAAP24-/n clone.
(A) PCR screening strategy for FAAP24-/n clone identification. HA: homology arm; Neo:
neomycin resistance gene cassette.
(B) PCR genotyping of the FAAP24-/n.
(a) PCR of targeted allele, knockout allele and wild type allele using indicated primers.
(b) PCR of wild type allele using both F24UpStrm/F24E3R and F24E3F/F24E4R primers.
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Finally, the neo cassettes were removed from the FANCM-/n and FAAP24-/n clones to
generate the FANCM-/- and FAAP24-/- somatic knockout cell lines. Genotyping of
representative clones for each genotype was shown in Figs 2.5A&B. Complete loss of gene
expression in FANCM-/- and FAAP24-/- knockout cell lines was verified by western blot (Fig
2.5C).
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Fig. 2.5 Generation of FANCM-/- and FAAP24-/- knockout cell lines.
(A) PCR genotyping of FANCM in representative clones.
(B) PCR genotyping of FAAP24 in representative clones.
(C) Western blot showing complete FANCM and FAAP24 protein loss in corresponding
somatic knockout cell lines.
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Generation of FANCM-/-/FAAP24-/- double knockout cell line
To generate the FANCM-/-/FAAP24-/- double knockout cell line, gene targeting of
FAAP24 was performed in FANCM-/- cells. First allele targeting resulted in six FANCM-/-/
FAAP24+/n clones out of ~1000 colonies screened. For the second allele targeting, one out of
~1300 colonies screened was positive for correct targeting of the remaining wild type
FAAP24 allele. This clone was expanded and the genotype was verified by PCR. Genotyping
of representative clones for each genotype was shown in Fig 2.6A. Finally, the neo cassette
was removed to generate the FANCM-/-/FAAP24-/- double knockout cell line. Complete loss
of gene expression was confirmed by western blot (Fig 2.6B).
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Fig. 2.6 Generation of FANCM-/-/FAAP24-/- double knockout cell line.
(A) PCR genotyping of FANCM and FAAP24 in representative clones.
(B) Western blot showing complete FANCM and FAAP24 protein loss in corresponding
somatic knockout cell lines.
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Generation of FANCB- knockout cell line
Gene targeting of FANCB was done by Dr. Yingjun Jiang (a former postdoctoral
fellow in Dr. Lei Li’s group). Since FANCB gene is located in X chromosome, only one
round of gene targeting was necessary to generate the null mutant. As shown in Fig 2.7A,
exon 2 was deleted through homologous replacement-mediated targeting. One FANCBn clone
was obtained and the genotype was confirmed by PCR (Fig 2.7B). I removed the neo
cassettes from this FANCBn clone and generated the FANCB- somatic knockout cell line.
Finally I did an IP-western and confirmed the loss of FANCB expression in the FANCBknockout cells (Fig 2.7C).
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Fig. 2.7 Generation of FANCB- knockout cell line.
(A) Schematics of FANCB targeting strategy. Numbered boxes indicate relative locations of
exons. HA: homology arm; TK: thymidine kinase gene promoter; Neo: neomycin resistance
gene cassette; L(R)-ITR: left (right) inverted tandem repeats. Locations of PCR screening
primers were also indicated.
(B) PCR genotyping of the FANCBn clone.
(C) IP-Western blot showing complete FANCB protein loss in the somatic knockout cell line.
Asterisk indicates nonspecific bands.
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Discussion
FANCM and FAAP24 functions have been implicated in the activation of FA
pathway, DNA damage checkpoint signaling, and suppression of crossover recombination.
However, lack of human genetic model systems restricted in-depth studies of how these
functions integrate to protect cells from DNA damage. While no patient mutations have been
identified for FAAP24, the only FANCM patient also harbors bi-allelic FANCA mutations
(Singh et al., 2009), rendering the true classification of this patient difficult. In this study, I
created isogenic human FANCM- and FAAP24-null mutants, which allow the functional
impact of FANCM and FAAP24 on DNA damage response to be precisely determined.
The fact that the FANCM patient harbors bi-allelic mutations of both FANCM and
FANCA makes whether FANCM is a bona fide Fanconi anemia gene controversial. In the
present study, the FANCM-/- somatic knockout cells are viable, and recapitulate cellular
hallmarks of Fanconi anemia (described in Chapter III). These results indicate the potential
existence of genuine FANCM patient(s). Similarly, the viability and the typical cellular FA
characteristics of FAAP24-/- somatic knockout cells (Chapter III) suggest the possibility of
FAAP24 patients. However, since the FA pathway activation is only partially impaired in the
absence of FANCM or FAAP24 (Chapter III), the clinical phenotypes of FANCM and
FAAP24 patients, if any, might be less severe compared with typical FA patients.
Generation of FANCM-/- and FAAP24-/- single mutants as well as FANCM-/-/FAAP24/-

double mutant allows the epistatic functions of FANCM and FAAP24 in DNA damage

response and repair to be determined. Although FANCM can form a heterodimer with
FAAP24 through its C-terminal ERCC-4 like endonuclease domain, it also contains other
domains including the translocase domain associated with ATP-dependent enzymatic activity,
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MM1 motif required for FA core complex interaction, and MM2 motif responsible for
Bloom’s complex association (Deans and West, 2009; Meetei et al., 2005). It is therefore
likely that FANCM may carry out additional functions independent of FAAP24. In fact,
while FANCM has been implicated in replication fork remodeling and SCE suppression,
whether FAAP24 is also involved in these functions remains unclear. On the other hand, the
apparent differential preference for DNA substrates of FANCM and FAAP24 (Ciccia et al.,
2007) indicates the possibility that FAAP24 may also possess FANCM-independent
functions. A systematic epistatic analysis will elucidate whether FANCM and FAAP24 are
interdependent for their functions in maintaining genomic stability.
In this study, a FANCB- somatic knockout cell line is also generated and included in a
number of functional studies of FANCM and FAAP24. This allows the dissection of both FA
core complex-associated and FA core complex-independent functions of FANCM and
FAAP24 in DNA damage response and repair.
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CHAPTER III
FANCM and FAAP24 Coordinately Activate the Fanconi Anemia Pathway and
Suppress Sister Chromatid Exchange

Introduction
FANCM was initially identified as FAAP250, a FANCA interacting protein in a
tandem affinity purification experiment. FAAP250 associates with known FA core complex
components and functions to promote FANCD2 monoubiquitination (Meetei et al., 2005).
FAAP250 mutations were found in a previously unclassified Fanconi anemia patient, and the
gene was therefore named FANCM (Meetei et al., 2005). However, biallelic mutations of
FANCA were later discovered in the same patient. To date, this patient remains to be the only
FA patient harboring FANCM mutations (Singh et al., 2009). Consequently, whether
FANCM is a bona fide FA gene appears controversial. Nevertheless, lymphoblasts from this
patient complemented with FANCA remains sensitive to MMC and display attenuated
FANCD2 monoubiquitination (Singh et al., 2009), consistent with si-RNA based knockdown
studies (Meetei et al., 2005), suggesting that FANCM functions to activate FA pathway.
FAAP24 was identified as a FANCM interacting partner (Ciccia et al., 2007), and
FANCM-FAAP24 complex structurally resembles that of the XPF-ERCC1 and Mus81Eme1/2 endonuclease complexes, suggesting that FAAP24 may function with FANCM in a
similar heterodimer. Consistently, like FANCM, FAAP24 also associates with FA core
complex, and cells devoid of FAAP24 display MMC sensitivity and defective FANCD2
monoubiquitiantion (Ciccia et al., 2007). Collectively, these studies suggest that FANCM
and FAAP24 are important for the activation of FA pathway.
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Unlike typical FA core complex components, FANCM and FAAP24 have DNA
interacting domains and activities. FANCM contains a DEAH helicase domain and
associated ATP-dependent translocase activity (Meetei et al., 2005). Both FANCM and
FAAP24 contain ERCC4-like nuclease domain, which are important for their in vitro DNA
binding (Ciccia et al., 2007). These properties of FANCM and FAAP24 may allow them to
function independently of the FA pathway. Indeed, FANCM has been shown to be required
for resistance to UV and campothecin (Singh et al., 2009). In addition, cells deficient for
FANCM display increased sister chromatid exchange, a phenotype seemingly not shared
with other FA core complex mutant cells (Bakker et al., 2009). Furthermore, FANCM and
FAAP24 have been implicated in the activation of ATR-mediated DNA damage checkpoint
(Collis et al., 2008; Huang et al., 2010; Luke-Glaser et al., 2009; Schwab et al., 2010). More
recently, FANCM has also been demonstrated to function in nucleotide excision repair and in
recombination-mediated processes (Crismani et al., 2012; Kelsall et al., 2012; Knoll et al.,
2012; Lorenz et al., 2012).
In this study, I sought to systematically study the functions of FANCM and FAAP24
in cellular response to ICL damage using an isogenic human genetic model system
established earlier (Chapter II). Unexpectedly, I found that FANCM-/-/FAAP24-/- double
knockout cells were much more sensitive to crosslinking agents than FANCM-/- and FAAP24/-

single knockout cells, suggesting that FANCM and FAAP24 functions are not fully

epistatic in response to ICL damage. This prompted me to define shared as well as unique
functions of FANCM and FAAP24 in DNA damage response and repair. I show in this
Chapter that FANCM and FAAP24 work in concert to activate the FA pathway and to
suppress crossover recombination. An extended study of the functions of FANCM and
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FAAP24 in DNA damage checkpoint signaling and actual ICL repair processes has also been
carried out, and the results will be described in following Chapters.
Materials and Methods
Antibodies
FANCL antibody was described previously (Meetei et al., 2003). Sources of
commercial antibodies not described in previous chapters are as follows: anti-β-tubulin
(T4026, Sigma-Aldrich); anti-FANCD2 (ab2187, Abcam; sc-20022, Santa Cruz;

and

NB100-182, Novus); anti-FANCA (A301-980A, Bethyl); anti-FANCG (NB100-2566,
Novus); anti-histone H3 (05-928, Millipore); anti-BLM (A300-110A, Bethyl); and
rhodamine Red-X-conjugated goat anti-rabbit (111-295-144, Jackson ImmunoResearch).
Clonogenic survival assay
Cells were seeded at a density of 1-3×105 cells per 100 mm culture plate and allowed
to attach and recover for overnight. Cells were then exposed to MMC or cisplatin at
escalating dosages for 1 hr. After drug treatment, cells were seeded at appropriate densities in
triplicates for each dosage group, and grown in drug-free medium for approximately 14 days.
Cell colonies were then fixed with 6% glutaraldehyde (v/v) and stained with 0.5% crystal
violet (w/v). Colonies containing more than 50 cells were counted, and relative survival was
calculated as follows: % survival = # colonies counted / (# cells plated × plating efficiency) ×
100.
Mitotic spread and SCE assay
For MMC-induced chromosomal abnormality analysis, cells were treated with 40
ng/ml MMC for 18 hrs, and mitotic spread was prepared as previously described (Wang et al.,

46

2006). Slides were stained with 4% Giemsa and chromosomal abnormalities were quantified
by scoring 40-80 metaphases.
For SCE assay, cells were cultured in the presence of 100 mM of 5bromodeoxyuridine for approximately 48 hrs to allow for twice of doubling. For MMCinduced SCE analysis, 20 ng/ml MMC were added 18 hrs before harvesting cells. Mitotic
spread preparation and slide staining were performed as previously described (Yin et al.,
2005). About 40 metaphases were scored for each sample.
Immunofluorescence staining
Cells were cultured on cover slips and treated with desired dosage of MMC for 24 hrs.
Cells were then washed with PBS, fixed with 3% formaldehyde for 15 min and
permeabilized with 0.5% Triton buffer (20 mM HEPES, pH7.4, 50 mM NaCl, 3 mM MgCl 2 ,
300 mM sucrose, 0.5% Triton-X-100) for 5 min at room temperature. Samples were
incubated sequentially with desired primary and secondary antibodies for 30 min, and finally
stained with 4’, 6-diamidino-2-phenylindole (DAPI) for 2 min in dark, all at room
temperature. Cover slips were mounted on slides with 1, 4-phenylenediamine based anti-fade
solution, and visualized under Nikon Eclipse 90i fluorescence microscopy. Nuclear foci were
counted in at least 100 nuclei at 5 different locations for each sample.
Cell fractionation
Cells were lysed with NETN buffer (20 mM Tris-HCl, pH 8.0,100 mM NaCl, 1.5
mM MgCl 2 , 1 mM EDTA, 0.5% Nonidet P-40, 10 mM NaF, 1 mM Na 3 VO 4 , 2 μg/ml
aprotinin, and 1μg /ml pepstatin) at 4 °C for 30 min and centrifuged at 14,000 rpm for 10 min.
The soluble fraction contains the cytosol and soluble nuclear proteins. The insoluble
chromatin enriched pellet was washed with phosphate buffered saline (PBS) for three times
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and extracted with 0.2 N HCl for 30 min on ice, and the extract was neutralized with equal
volume of 1 M Tris-HCl (pH 8.0).
Results
FANCM-/- and FAAP24-/- somatic knockout cells are hypersensitive to interstrand
crosslinking agents
A characteristic cellular hallmark of FA is hypersensitivity to DNA interstrand
crosslinking agents such as mitomycin C (MMC), which manifests as reduced survival and
increased chromosomal abnormalities (Moldovan and D'Andrea, 2009). To test whether the
FANCM-/- and FAAP24-/- somatic knockout cells display typical FA cellular phenotypes, I
first exposed them to different concentrations of MMC and compared their survival to wild
type HCT-116 cells. As shown in Fig 3.1A, cells lacking FANCM or FAAP24 showed
significantly reduced cellular survival in response to MMC. Similar results were also
obtained when exposing cells to another interstrand crosslinking agent cisplatin (Fig 3.1B).
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Fig. 3.1 FANCM and FAAP24 deficient cells are hypersensitive to ICL agents.
(A) Clonogenic survival of FANCM and FAAP24 knockout cell lines treated with MMC.
Error-bars represent standard deviations from four independent experiments with triplicated
plates.
(B) Clonogenic survival of FANCM and FAAP24 knockout cell lines treated with cisplatin.
Error-bars represent standard deviations from four independent experiments with triplicated
plates.
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I then exposed FANCM-/- and FAAP24-/- somatic knockout cells to a low
concentration of MMC, and examined metaphase cells for chromosome abnormalities. Cells
deficient for FANCM or FAAP24 displayed increased levels of chromosome breakage
compared to wild type cells (Fig 3.2), reflecting another typical FA cellular feature.
Collectively, these data demonstrate that FANCM-/- and FAAP24-/- somatic knockout
cells recapitulate characteristic FA cellular hallmarks, and suggest that FANCM and
FAAP24 are important for cellular resistance to interstrand crosslink damage.
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Fig. 3.2 FANCM and FAAP24 deficient cells display increased chromosome breakage in
response to ICL damage.
(A) Chromosome breakage in FANCM and FAAP24 knockout cell lines exposed to MMC
(40 ng/ml for 18 hr). Arrows indicate visible chromosome breaks.
(B) Quantification of chromosomal abnormality in FANCM and FAAP24 knockout cell lines.
40 metaphase spreads were scored for each cell line. Bars represent average chromosomal
breakage per spread.
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FANCM and FAAP24 possess non-overlapping functions in cellular resistance to ICL
damage
The isogenic property of the FANCM and FAAP24 mutants allowed direct
comparison of their hypersensitivities to crosslinking agents. Compared with FANCM-/- and
FAAP24-/- single knockout cells, the FANCM-/-/FAAP24-/- double knockout cells were much
more sensitive to both MMC and cisplatin in terms of cellular survival (Figs 3.1A&B).
Consistently, the double mutant also had significantly higher frequency of MMC-induced
chromosomal breakages than either single mutant (Fig 3.2). These data strongly indicate that
FANCM and FAAP24 may possess non-overlapping functions in response to DNA
interstrand crosslinking damage.
FANCM and FAAP24 cooperatively support activation of the Fanconi anemia pathway
Compared to FANCM-/- and FAAP24-/- cells, the FANCM-/-/FAAP24-/- double
knockout cells displayed more chromosome breaks and lower survival when treated with
MMC (Fig 3.1A & Fig 3.2). One plausible explanation could be that FANCM and FAAP24
are redundant in FA pathway activation. To test this hypothesis, I examined FANCD2
monoubiquitination, a marker of FA pathway activation, in cells lacking FANCM and/or
FAAP24. As shown in Figs 3.3A&B, MMC-induced FANCD2 monoubiquitination in
FANCM-/- and FAAP24-/- cells was significantly reduced compared with that in wild type
cells, and the defects could be rescued by re-expressing wild type FANCM or FAAP24
proteins (Fig 3.4). These data suggest that FANCM and FAAP24 promote the FA pathway
activation.

In

contrary

to

my

hypothesis

however,

MMC-induced

FANCD2

monoubiquitination in FANCM-/-/FAAP24-/- double knockout cells was at a comparable level
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to those in FANCM-/- and FAAP24-/- cells (Fig 3.3C), suggesting that FANCM and FAAP24
work together to promote the activation of FA pathway.
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Fig. 3.3 FANCM and FAAP24 promote FANCD2 monoubiquitination.
(A-C) Immunoblots detecting FANCD2 monoubiquitination in cells with indicated genotypes,
treated or mock-treated with MMC (200 ng/ml, 16 hrs). L and S represent monoubiquitinated
and native forms of FANCD2, respectively.

56

57

Fig. 3.4 Re-expression of FANCM and FAAP24 restores FANCD2 monoubiquitination in
FANCM-/- and FAAP24-/- knockout cell lines.
(A) Immunoblot detecting MMC-induced monoubiquitination of FANCD2 in FANCM-/- cells
complemented with wild-type Flag-FANCM. L and S represent monoubiquitinated and
native forms of FANCD2, respectively.
(B) Immunoblot detecting MMC-induced monoubiquitination of FANCD2 in FAAP24-/- cells
complemented with wild-type Flag-FAAP24. L and S represent monoubiquitinated and
native forms of FANCD2, respectively.
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In addition, MMC-induced FANCD2 nuclear foci formation was remarkably
diminished in FANCM-/-, FAAP24-/- and FANCM-/-/FAAP24-/- cells, and the levels of
reduction in all three mutants were comparable (Fig 3.5). The defective FANCD2 foci
formation in FANCM-/- and FAAP24-/- cells could be corrected by re-expressing the wild type
proteins (Fig 3.6). These data further support that FANCM and FAAP24 promote FA
pathway activation in a non-redundant manner.
Notably, in FANCB- knockout cells, FANCD2 monoubiquitination and nuclear foci
formation were completely abolished (Fig 3.3B & Fig 3.5). This result suggests that unlike
other FA proteins within the core complex, FANCM and FAAP24 are not indispensable for
FA pathway activation, although they strongly promote this process.
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Fig. 3.5 FANCM and FAAP24 promote FANCD2 nuclear foci formation.
(A) Formation of MMC-induced (500 ng/ml) FANCD2 nuclear foci in cells with indicated
genotypes.
(B) Quantification of FANCD2 nuclear foci formation in cells with indicated genotypes.
Data represent three independent experiments and error bars depict standard deviation
derived from 5 data sets.
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Fig. 3.6 Re-expression of FANCM and FAAP24 restores FANCD2 nuclear foci formation in
FANCM-/- and FAAP24-/- knockout cell lines.
(A) Formation of MMC-induced (500 ng/ml) FANCD2 nuclear foci in FANCM and FAAP24
knockout cells stably complemented with wild type proteins.
(B) Quantification of FANCD2 nuclear foci formation in FANCM and FAAP24 knockout
cells stably complemented with wild type proteins. Data represent three independent
experiments and error bars depict standard deviation derived from 5 data sets.
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To investigate how FANCM and FAAP24 promote FA pathway activation, I
examined whether FANCM and FAAP24 facilitate FANCD2 monoubiquitination by
recruiting the FA core E3 ligase complex. To this end, I examined the chromatin loading of
FA core complex and FANCD2 in response to MMC. As is shown in Fig 3.7, the recruitment
of FANCA, FANCG, and FANCL to chromatin was remarkably reduced in FANCM-/- and
FAAP24-/- cells compared with that in wild type cells. The chromatin association of FA core
complex proteins were identically reduced in the FANCM-/-/FAAP24-/- cells (Fig 3.7),
indicating that FANCM and FAAP24 cooperatively promote the chromatin loading of FA
core complex to facilitate FACND2 monoubiquitination and its chromatin localization. In
addition, in the absence of FAAP24, a larger amount of FANCM proteins were retained in
the soluble fraction, leading to decreased amount of chromatin-associated FANCM (Fig 3.7).
Similarly, the chromatin association of FAAP24 was greatly reduced in FANCM-/- cells (Fig
3.7). These data suggest that FANCM and FAAP24 facilitate the chromatin association of
each other, and they work in concert to promote the FA pathway activation.
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Fig. 3.7 FANCM and FAAP24 promote chromatin loading of FA core complex. Chromatin
association of FANCM, FAAP24, FANCA, FANCG, FANCL and FANCD2 in response to
MMC treatment (200 ng/ml, 6 hrs) was detected by Western blot.
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FANCM and FAAP24 cooperatively suppress sister chromatid exchange
Increased levels of sister chromatid exchanges (SCEs) have been reported in chicken
DT40 cells, mouse embryonic fibroblasts (MEFs) as well as human HEK293 cells that are
deficient for FANCM (Bakker et al., 2009; Deans and West, 2009; Rosado et al., 2009).
However, it is unclear whether FAAP24 also works to suppress SCE. To address this
question, I examined the somatic knockout cells lacking FANCM and/or FAAP24 for SCEs.
As shown in Fig 3.8, both the basal and MMC-induced SCE levels were significantly higher
in FANCM-/- cells compared with those in wild type cells, consistent with previous studies
(Bakker et al., 2009; Deans and West, 2009; Rosado et al., 2009). In addition, FAAP24-/cells also displayed markedly increased SCE levels (Fig 3.8), suggesting FAAP24 is also
required to suppress SCE formation. Notably, FANCM-/-/FAAP24-/- double knockout cells did
not produce any additional SCE phenotype than each single mutant alone, strongly indicating
that FANCM and FAAP24 work in a same pathway to suppress SCE.
Interestingly, cells deficient for FANCB did not have increased SCE levels compared
with wild type cells (Fig 3.8), consistent with data derived from MEFs lacking FANCA
(Bakker et al., 2009), suggesting that the function of FANCM-FAAP24 in suppressing SCE
formation is likely independent of the FA core complex.
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Fig. 3.8 FANCM and FAAP24 suppress sister chromatid exchange.
(A) Representative metaphase chromosome spreads showing MMC-induced SCEs (arrows)
in FANCM and FAAP24 knockout cells.
(B) Quantification of basal level (mock-treated) and MMC-induced (20 ng/ml for 18 hrs)
SCEs in FANCM and FAAP24 knockout cells. 30 metaphases were scored for each sample
and bars represent averages. The asterisks (*) denote P < 0.01 vs. wild type.
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Recent studies suggested that elevated SCE levels in FANCM deficient cells is likely
due to the loss of FANCM’s interaction with and recruitment of the BLM helicase (Deans
and West, 2009; Hoadley et al., 2012). I therefore tested whether the increased SCE levels in
cell lacking FANCM and/or FAAP24 were due to compromised recruitment of the Bloom’s
complex. To this end, I examined BLM foci formation in wild type and the knockout cell
lines. Surprisingly, the basal level as well as MMC-induced BLM foci formation was not
visibly affected in the absence of FANCM, FAAP24, or both (Fig 3.9). This indicates that
there exists a FANCM- and FAAP24-independent mechanism for BLM recruitment. It also
suggests that FANCM and FAAP24 may have BLM-independent functions in suppressing
SCE formation.
The increased SCE levels observed in FANCM and FAAP24 deficient cell lines
indicate a possibility that FANCM and FAAP24 act to suppress crossovers during
recombination-mediated repair. Consistently, I found that FANCM-/- and FAAP24-/- cells
displayed significantly increased formation of tetra-radial chromosome structures when
exposed to MMC (Fig 3.10). The FANCM-/-/FAAP24-/- cells had comparable amounts of
tetra-radial chromosomes compared with FANCM-/- and FAAP24-/- cells, further suggesting
that the suppression of crossover formation is cooperatively achieved by FANCM and
FAAP24, most likely through function of the heterodimer formed between the two proteins.
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Fig. 3.9 Loss of FANCM and FAAP24 does not affect MMC-induced BLM nuclear foci
formation.
(A) Immunofluorescent staining of BLM foci in FANCM and FAAP24 knockout cells treated
or mock treated with MMC (80 ng/ml or 500 ng/ml for 24 hr).
(B) Quantification of BLM nuclear foci in mock-treated and MMC-treated cells with
indicated genotypes. Data are representative of two independent experiments, and error bars
represent standard deviation of 5 datum points.
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Fig. 3.10 FANCM and FAAP24 suppress radial chromosome formation.
(A) Representative picture of tetra-radial chromosome formation in MMC-treated (20 ng/ml
for 18 hr) cells with indicated genotypes.
(B) Quantification of radial chromosome formation in cells with indicated genotypes. 80
metaphase spreads were scored for each genotype. Error bars represent standard deviation of
4 datum points. The asterisks (*) denote P < 0.01 vs. wild type.
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Discussion
FANCM and FAAP24 have been assumed to function together as a heterodimer due
to their structural resemblance to the heterodimeric endonucleases XPF/ERCC1 and
Mus81/Eme1, their co-purification, and their coordinated biochemical activities. In the
present study however, I found that the FANCM-/-/FAAP24-/- double knockout cell line was
much more sensitive to ICL damage than either FANCM-/- or FAAP24-/- single knockout cell
lines (Fig 3.1 & Fig 3.2), suggesting that FANCM and FAAP24 are not fully epistatic in
mediating ICL resistance.
This result may not be surprising for a number of reasons. First, Western blot showed
that FANCM and FAAP24 are not obligated heterodimers (Fig 2.5C & Fig 2.6B), suggesting
that each protein may have important cellular functions independent of the other. Second,
there exist protein complexes which contain only one of the FANCM and FAAP24 proteins.
For example, FANCM can form either homodimers or FANCM-MHF complex independent
of FAAP24 (Xue et al., 2008; Yan et al., 2010), while a significant fraction of FAAP24 was
observed not to co-migrate with FANCM in gel filtration experiments (Collis et al., 2008).
Third, FANCM and FAAP24 can each independently bind DNA substrates in vitro, and they
have preferences to different substrates such that FANCM binds branched DNA structures
while FAAP24 has high affinity towards ssDNA (Ciccia et al., 2007; Gari et al., 2008b).
Fourth, the different architectures of these two proteins may also confer diverged biological
functions. FANCM possesses an ATP-dependent DNA translocase activity, which has been
shown to be independent of FAAP24 in vitro (Gari et al., 2008b). In addition, FANCM
contains domains that mediate additional physical and functional protein interactions not
requiring FAAP24 (Deans and West, 2009). On the other hand, FAAP24 has a more
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conserved (HhH) 2 domain, especially the first HhH motif which contains a canonical
glycine-hydrophobic residue-glycine (GhG) hairpin critical for DNA binding (Ciccia et al.,
2007; Ciccia et al., 2008).
Nevertheless, the fact that the FANCM-/-/FAAP24-/- double mutant gives rise to
significantly increased damage sensitivity compared to each single mutant alone prompted
me to identify both epistatic and non-epistatic functions of FANCM and FAAP24 in response
to ICL damage.
The epistatic function between FANCM and FAAP24 are reflected by the comparable
phenotypes of the FANCM-/- and FAAP24-/- single mutants and the FANCM-/-/FAAP24-/double mutant. I found that FANCD2 monoubiquitination and nuclear foci formation in
response to ICL damage were affected to the same extent in the single and double mutants. I
also showed that MMC-induced tetraradial chromosome formation and SCEs occur with
equal frequencies among all three mutants. These data suggest that FANCM and FAAP24
function cooperatively to activate the FA pathway and to suppress crossover recombination
and SCE formation. The non-epistatic functions of FANCM and FAAP24 are described in
following chapters.
It has been shown that the recruitment of FA core complex upon DNA damage is
mediated by the MM1 motif in FANCM (Deans and West, 2009). However, my results show
that FAAP24 deletion also impairs damage-induced chromatin association of the core
complex, identically to the FANCM mutant (Fig 3.7), suggesting that recruitment of FA core
complex require both FANCM and FAAP24. Consistently, the FANCM-/- and FAAP24-/- cells
showed comparably defective FANCD2 monoubiquitination and nuclear foci formation.
Furthermore, FANCM-/-/FAAP24-/- double mutant showed no further defects in FANCD2
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monoubiquitination and nuclear foci formation, suggesting that FANCM and FAAP24 work
together to promote the activation of FA pathway. This is most likely attributed to the
cooperative binding of stalled DNA replication fork by FANCM and FAAP24. The preferred
substrates for FANCM and FAAP24 are fork structure and ssDNA, respectively. On the
other hand, the FANCM associated MHF complex prefers dsDNA substrates. Therefore, it is
plausible that these proteins bind to different parts of a stalled replication fork, such that
FANCM binds the branch point, and MHF complex and FAAP24 binds dsDNA and ssDNA
regions, respectively (Yan et al., 2010). Cooperatively, they protect the replication fork and
recruit the FA core complex.
Consistent with previous studies using various model systems (Bakker et al., 2009;
Deans and West, 2009; Rosado et al., 2009), I found that cells lacking FANCM showed
increased levels of SCE (Fig 3.8). Interestingly, I demonstrated that FAAP24 was also
required to suppress SCE formation in response to ICL damage, similar to a previous study
showing MHF1 functions with FANCM to suppress SCE (Yan et al., 2010). These results
suggest that FANCM and its binding partners function coordinately in SCE repression. On
the other hand, while it has been reported that the coordinated recruitment of FA core
complex and Bloom’s complex by FANCM is important for suppression of SCE formation
(Deans and West, 2009), my data indicate that the function of FANCM and FAAP24 in SCE
suppression is likely independent of FA core complex or BLM (Fig 3.8 & Fig 3.9). Possibly,
there exists a FANCM-independent mechanism to support BLM recruitment to ICL sites,
where damage-induced homologous recombination occurs between sister chromatids.
Mechanistically, the role of FANCM and FAAP24 in limiting crossover and
suppressing SCE formation in response to ICL damage may be attributed to the replication-
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fork remodeling activities. FANCM has the ability to convert a replication-fork structure to a
four-way junction in vitro, causing a replication fork regression (Gari et al., 2008a).
Therefore, it is plausible that FANCM mediates fork regression to generate a movable fourway junction in response to replication stress, and facilitates the re-start of blocked forks
through a mechanism that avoids crossover recombination and SCE. Since such functions are
associated with intrinsic enzymatic activity of FANCM, it is likely that FANCM can
suppress SCE formation independent of FA core complex and Bloom’s complex.
Alternatively, FANCM may function to limit crossovers in homologous recombination. In
fact, FANCM could promote branch migration of Holliday junction structures in vitro (Gari
et al., 2008b; Xue et al., 2008). In addition, like its yeast orthologs Fml1 (S. Pombe) and
Mph1 (S. cerevisiae), recombinant human FANCM protein is able to dissociate D-loop
structures in vitro (Gari et al., 2008a; Prakash et al., 2009; Sun et al., 2008). Furthermore,
FANCM orthologs in fission yeast and plants are important for limiting crossovers during
meiosis (Crismani et al., 2012; Knoll et al., 2012; Lorenz et al., 2012). It is therefore possible
that human FANCM plays an important role in limiting crossover and suppressing SCE
formation via yet to defined functions in homologous recombination.
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CHAPTER IV
FAAP24 Promotes ATR-mediated Checkpoint Activation in Response to Interstrand
Crosslink Damage

Introduction
The DNA interacting activities set FANCM and FAAP24 apart from other FA core
complex components. The coordinated DNA binding activity of the FANCM-FAAP24
heterodimer and the translocase activity of FANCM likely allow them to act as DNA damage
sensing components. Indeed, FANCM and FAAP24 have been shown to be constantly
associated with chromatin and are believed to be important for the loading of FA core
complex in response to DNA damage (Kim et al., 2008). While the activation of FA pathway
in response to ICL damage is important for the crosslinking damage repair, this pathway has
to coordinate with other damage-responsive pathways to ensure ICL repair carried out in an
orderly manner. Presumably functioning in the initiation of FA pathway activation, FANCM
and FAAP24 are plausible candidates that convey signals to DNA damage checkpoint
signaling pathways.
Whether the potential function of FANCM and FAAP24 as DNA damage sensors is
specifically linked to ICL damage is uncertain. However, given their FA core complexindependent DNA binding and translocating activities, it is likely they also function in
response to other types of DNA damage. In fact, FANCM mutant has been shown to be
sensitive to UV light and replication stress inducers (Singh et al., 2009). Therefore, it will be
interesting to dissect whether and how FANCM and FAAP24 function in cellular response to
DNA damage other than ICL, such as UV and HU.
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A number of studies have addressed the potential function of FANCM and FAAP24
in ATR-mediated checkpoint signaling (Collis et al., 2008; Huang et al., 2010; Luke-Glaser
et al., 2009; Schwab et al., 2010). Using siRNA based studies, Collis et al and others have
shown that FANCM and FAAP24 are required for optimal activation of ATR-mediated
checkpoint signaling in response to UV and HU (Collis et al., 2008; Luke-Glaser et al., 2009;
Schwab et al., 2010). A more recent study, however, demonstrated that the function and
FANCM and FAAP24 in checkpoint activation seems to be specifically associated with
response to ICL damage (Huang et al., 2010).
In this Chapter, I describe genetic studies that investigate the function of FANCM and
FAAP24 in DNA damage checkpoint signaling, particularly the ATR-mediated checkpoint
pathway. I provide genetic evidence demonstrating FAAP24, but not FANCM, is required
for activation of the ATR-dependent checkpoint signaling in response to ICL damage, and
neither protein seems to be essential for ATR-mediated checkpoint activation in response to
UV and HU. Discussions addressing discrepancies among studies will be presented, which
help to better understand the FANCM and FAAP24 function in ATR-dependent checkpoint
signaling in response to different types of DNA damage.
Materials and Methods
Antibodies
Sources of antibodies (that were not described in previous chapters) are as follows:
anti-Chk1 (sc-8408, Santa Cruz); anti-phospho-Chk1 Ser317 (2344, Cell Signaling); antiphospho-Chk1 Ser345 (2348, Cell Signaling); anti-phospho-histone H3 Ser10 (9706, Cell
Signaling); anti-Myc (sc-40, Santa Cruz); and fluorescein isothiocyanate (FITC)-conjugated
rabbit anti-mouse.
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Co-immunoprecipitation
Constructs expressing Flag-tagged FANCM and Myc-tagged FAAP24 (wild type or
V198A mutant) were co-transfected into HEK293T cells. 18 hours later, cells were lystated
in NETN buffer supplemented with Benzonase nuclease for 1 hour at 4 °C. After
centrifugation, supernatants were collected and subjected to immunoprecipitation with antiMyc antibodies for overnight at 4 °C. Proteins bound with the anti-Myc antibodies were then
recovered by incubating the lysates with protein G beads, and detected by western blot.
Cell cycle checkpoint analysis
G2/M checkpoint analysis was performed as described earlier (Wang et al., 2003).
Briefly, cells were treated with MMC (1000 ng/ml for 6 or 16 hrs) or IR (6 Gy for 90 min or
10 Gy for 2 hrs), harvested, and fixed with 70% ethanol at 20 °C overnight. Fixed cells were
permeabilized with 0.25% Triton X-100/ PBS buffer on ice for 15 min and then sequentially
incubated with anti-phospho-histone H3 antibody (1:30 in 1% BSA/PBS) at room
temperature for 3 h and FITC-conjugated secondary antibody (1:50 in 1% BSA/PBS) in the
dark at room temperature for 30 min. Cells were finally stained with propidium iodide (PI)
buffer (0.2 mg/ml RNase A and 5 µg/ml PI in PBS) in the dark at room temperature for 30
min, and percentage of cells with positive phospho-histone H3 staining was determined by
flow cytometry analysis.
Results
FANAM and FAAP24 are not required for ATR-mediated checkpoint activation in
response to HU or UV
Unlike other FA proteins among the FA core complex, FANCM and FAAP24 both
possess DNA-interacting domains. The associated DNA interacting activities might be
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important for FANCM and FAAP24 to function independently of the FA core complex in
DNA damage response pathways, therefore connecting the FA pathway to DNA damage
response signaling network. Particularly, the potential functions of FANCM and FAAP24 in
ATR-mediated checkpoint and G2/M checkpoint activation have been explored by a few
studies (Collis et al., 2008; Huang et al., 2010; Luke-Glaser et al., 2009; Schwab et al., 2010).
However, the results reported were not fully consistent.
To determine whether FANCM and FAAP24 are important for the activation of ATRmediated checkpoint, I exposed FANCM-/-, FAAP24-/-, and FANCM-/-/FAAP24-/- knockout
cells to various DNA damage agents, and assessed ATR-mediated checkpoint activation by
measuring Chk1 phosphorylation. As shown in Fig 4.1A, when exposed to hydroxyurea
(HU), FANCM-/-, FAAP24-/-, and FANCM-/-/FAAP24-/- knockout cells did not display any
visible defect in Chk1 phosphorylation at Ser317. Similarly, when exposed to UV, cells
lacking FANCM and/or FAAP24 did not show any apparent defect in activating the
ATR/Chk1 signaling (Fig 4.1B). These experiments were repeated numerous times using
different doses of HU and UV, with Chk1 phosphorylation examined at multiple time points.
In all experimental conditions tested, lack of FANCM and FAAP24 did not result in visible
effects on ATR-dependent checkpoint activation, both in terms of the initial onset and
dose/time-dependent accumulation of Chk1 phosphorylation (data not shown).
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Fig. 4.1 FANCM and FAAP24 are not required for ATR-mediated checkpoint activation in
response to HU or UV.
(A) Ser317 phosphorylation of Chk1 in FANCM and FAAP24 mutant cells exposed to HU (1
mM) and harvested at indicated time points. Chk1 and β-Actin serve as loading controls.
(B) Ser317 phosphorylation of Chk1 in FANCM and FAAP24 mutant cells exposed to UV
(20 J/m2) and harvested at indicated time points. Chk1 and β-Actin serve as loading controls.
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When cells are treated with HU or UV, the replication stress will lead to uncoupling
of the replicative helicase and polymerase. Unwinding of DNA by the helicase ahead of the
stalled replication fork will efficiently generate a long stretch of ssDNA, which will be
coated rapidly by ssDNA binding protein RPA. RPA will recruit the ATR binding partner
ATRIP, and initiate the ATR/Chk1 signaling, thereby activating the ATR-mediated
checkpoint. I examined HU and UV induced RPA foci formation in FANCM-/-, FAAP24-/-,
and FANCM-/-/FAAP24-/- knockout cells, and found that lack of FANCM and/or FAAP24 did
not result in reduced RPA foci assembly (Fig 4.2), consistent with the intact checkpoint
activation. Collectively, these results suggest that FANCM and FAAP24 are dispensable for
ATR-mediated checkpoint activation in response to HU and UV.
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Fig. 4.2 FANCM and FAAP24 are not required for RPA foci formation in response to HU or
UV.
(A) Immunofluorescent staining of RPA2 foci in FANCM and FAAP24 mutant cells treated
with UV or HU.
(B) Quantification of RPA2 foci in UV or HU treated cells with indicated genotypes. Data
are representative of two independent experiments, and error bars represent standard
deviation of 5 datum points.
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FAAP24 promotes ATR-mediated checkpoint activation in response to MMC
In contrast to the HU and UV treatment, when cells are exposed to interstrand
crosslinking agents, both the replicative helicase and polymerase will be stalled. As a result,
the generation of ssDNA will be less efficient. How ATR-mediated checkpoint gets activated
in this scenario is not well understood.
To examine whether FANCM and FAAP24 are required for ATR-mediated
checkpoint activation in response to ICL damage, I exposed FANCM-/-, FAAP24-/-, and
FANCM-/-/FAAP24-/- knockout cells to MMC, and examined Chk1 phosphorylation. As
shown in Fig 4.3, FAAP24 but not FANCM deficiency, resulted in compromised activation
of ATR-mediated checkpoint in response to MMC, as demonstrated by decreased
phosphorylation of Chk1 at both Ser317 and Ser345. Collectively, these results suggest that
FANCM is not essential for ATR-mediated checkpoint activation, and FAAP24 is
specifically required for activating ATR-Chk1 signaling in response to ICL damage.
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Fig. 4.3 FAAP24 promotes ATR-mediated checkpoint activation in response to MMC.
(A) Ser317 phosphorylation of Chk1 in FANCM and FAAP24 mutant cells exposed to MMC
(150 ng/ml) and harvested at indicated time points. Chk1 and β-Actin serve as loading
controls.
(B) Ser317 and Ser345 phosphorylation of Chk1 in FANCM and FAAP24 mutant cells
exposed exposed to MMC (150 ng/ml) and harvested at indicated time points. Chk1 and βActin serve as loading controls.
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To determine whether the ATR-mediated checkpoint activation defect in cells lacking
FAAP24 was due to deficient RPA recruitment, I examined MMC-induced RPA nuclear foci
formation in the knockout cell lines. As shown in Fig 4.4, although RPA foci assembly in
response to MMC treatment was inefficient in cells lacking FANCM and/or FAAP24, the
FANCM-/-, FAAP24-/-, and FANCM-/-/FAAP24-/- cells did not display reduced RPA foci
formation compared with wild type cells. At later time points, RPA foci were efficiently
assembled in both wild type cells and cells deficient for FANCM and/or FAAP24 (Fig 4.4),
probably reflecting robust RPA recruitment in response to double strand break formation
caused by prolonged replication fork stall. These data suggest that FAAP24 is important for
optimal ATR-mediated checkpoint activation in response to ICL damage, when RPA
recruitment was relatively inefficient. The function of FAAP24 in this context is mostly
likely attributed to the intrinsic affinity of FAAP24 to ICL DNA (Huang et al., 2010), which
might be important for recruitment of ATR co-activators and therefore activation of the
ATR-mediated checkpoint signaling pathway.
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Fig. 4.4 FANCM and FAAP24 are not required for RPA foci formation in response to MMC.
(A) Immunofluorescent staining of RPA2 foci in FANCM and FAAP24 mutant cells treated
with MMC.
(B) Quantification of RPA2 foci in MMC treated cells with indicated genotypes. Data are
representative of two independent experiments, and error bars represent standard deviation of
5 datum points.
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The role of FAAP24 in ICL-induced ATR-mediated checkpoint activation is
independent of its interaction with FANCM
In response to ICL damage, cells deficient for FAAP24 were defective in activating
the ATR-mediated checkpoint. However, the ICL-induced ATR-mediated checkpoint
activation was not affected by the loss of FANCM. These results suggest that FAAP24 is
able to mediate checkpoint signal activation without forming the heterodimeric complex with
FANCM. To test this notion, I sought to determine whether the interaction with FANCM is
required for the function of FAAP24 in activating the ATR-mediated checkpoint signaling in
response to DNA interstrand crosslinking agents.
FAAP24 interacts with FANCM through its (HhH) 2 domain (see Chapter VI for
detail). I therefore disrupted a few amino acids within this domain in order to generate a
FAAP24 mutant that is defective for FANCM binding. Specifically, I substituted the Val198,
Val199 and Gly200 residues with alanines and generated the FAAP24-V198A mutant. The
interaction of wild type and mutant FAAP24 with FANCM was examined by Co-IP
experiment. As shown in Fig 4.5A, the FAAP24-V198A mutant failed to interact with
FANCM.
To test whether the FAAP24-V198A mutant can correct the ATR-mediated
checkpoint activation defect caused by FAAP24 loss, I stably expressed the mutant in the
FAAP24-/- knockout cell line (Fig 4.5B). A wild type FAAP24 complemented FAAP24-/- cell
line was also established as a control. When exposed to MMC, Chk1 phosphorylation at
Ser317 in both wild type FAAP24 and V198A mutant complemented FAAP24-/- cells was
comparable to that in wild type HCT-116 cells, suggesting that the FAAP24-V198A mutant
was able to rescue the ATR-mediated checkpoint deficiency associated with lack of the
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FAAP24 gene. This result supports that the checkpoint activation function of FAAP24 is
independent of its interaction with FANCM.
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Fig. 4.5 The ATR-mediated checkpoint activation function of FAAP24 is independent of its
interaction with FANCM.
(A) Co-immunoprecipitation of wild-type FAAP24 and the FAAP24-V198A mutant with
FANCM.
(B) MMC-induced Chk1 activation in FAAP24-/- cells complemented with Flag-FAAP24wild type or Flag-FAAP24-V198A mutant.
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FANCM-associated FA pathway activation function and FANCM-independent ATRmediated checkpoint activation function of FAAP24 are both required for resistance to
ICL damage
While FAAP24 act together with FANCM to activate the FA pathway, its function in
ATR-mediated checkpoint activation in response to ICL is independent of FANCM. This
suggests that the function of FAAP24 in FA pathway activation and its function in ATRmediated checkpoint activation can be segregated. To determine whether both functions are
important for cellular resistance to ICL damage, I tested wild type FAAP24 and V198A
mutant complemented FAAP24-/- cells for cellular survival in response to MMC damage. As
shown in Fig 4.6, while wild type FAAP24 protein fully rescued the hypersensitivity of
FAAP24-/- cells to MMC, the FAAP24-V198A mutant was only able to partially rescue the
MMC sensitivity of FAAP24-/- knockout cells. These results suggest that both the FANCMassociated FA pathway activation function and the FANCM-independent ATR-mediated
checkpoint activation function of FAAP24 are required for protecting cells against ICL
damage.
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Fig. 4.6 Clonogenic survival of FAAP24-/- cells complemented with Flag-FAAP24-wild type
or Flag-FAAP24-V198A. Error-bars represent standard deviations from three independent
experiments with triplicated plates.
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FANCM and FAAP24 are not required for G2/M checkpoint activation in response to
MMC or IR
To determine whether FANCM and FAAP24 are involved in the activation of G2/M
checkpoint in response to DNA damage, I first exposed the FANCM-/-, FAAP24-/-, and
FANCM-/-/FAAP24-/- knockout cells to MMC, and examined mitotic entry by phosphorylated
histone H3 staining based flow cytometry analysis. As shown in Fig 4.7, cells lacking
FANCM and/or FAAP24 were proficient in activating G2/M checkpoint in response to
different doses of MMC. When treated with ionizing radiation (IR), the FANCM-/-, FAAP24-/-,
and FANCM-/-/FAAP24-/- knockout cells were also competent in the activation of G2/M
checkpoint (Fig 4.8). These data suggest that FANCM and FAAP24 are dispensable for
efficient G2/M checkpoint activation in response to DNA damage.
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Fig. 4.7 Loss of FANCM and FAAP24 does not affect G2/M checkpoint activation in
response to MMC. Cells were treated with MMC, and phospho-histone H3 staining was
determined by flow cytometry analysis.
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Fig. 4.8 Loss of FANCM and FAAP24 does not affect G2/M checkpoint activation in
response to IR. Cells were treated with IR, and phospho-histone H3 staining was determined
by flow cytometry analysis.
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Discussion
FANCM and FAAP24 have been implicated in ATR-mediated DNA damage
checkpoint signaling by separate studies (Collis et al., 2008; Huang et al., 2010; Luke-Glaser
et al., 2009; Schwab et al., 2010), although the results reported were not fully consistent. In
the present study, I found that FANCM and FAAP24 are not important for efficient ATR
activation in response to UV or HU (Fig 4.1). This appears to be in agreement with studies
by Huang et al (Huang et al., 2010), but is contradictory to a few other studies (Collis et al.,
2008; Luke-Glaser et al., 2009; Schwab et al., 2010). I also found that FAAP24 but not
FANCM promotes ATR-mediated checkpoint activation in response to DNA crosslinking
agents (Fig 4.3), which is partially consistent with a previous report (Huang et al., 2010).
A key step in ATR-mediated checkpoint activation is extensive exposure of ssDNA
and its coating by RPA, which recruits the ATR binding partner ATPIP and the ATR kinase
itself. ATR activation then follows recruitment of RFC-like Rad17/Rfc2-5 clamp-loader,
PCNA-like Rad9-Rad1-Hus1 (9-1-1) clamp, and additional co-activators such as TopBP1
(Burrows and Elledge, 2008). In response to UV or HU damage, while the DNA polymerase
is stalled by damaged DNA, the replicative helicase can proceed and therefore excessively
expose ssDNA. This polymerase-helicase uncoupling allows the RPA coated ssDNA to
promptly accumulate, which in turn leads to efficient ATR recruitment and robust activation
of ATR and the DNA damage checkpoint signaling. FANCM and FAAP24 have been shown
to interact with HCLK2, which also associates with ATR-ATRIP complex, and have
therefore been speculated to be important for ATR recruitment and activation (Collis et al.,
2008; Horejsi et al., 2009). It is likely that previous studies (Collis et al., 2008; Luke-Glaser
et al., 2009; Schwab et al., 2010) employing siRNA depletion reflect a more acute
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consequence of FANCM and FAAP24 loss. In contrast, the knockout cell lines used in this
study may have adapted to the loss of FANCM and FAAP24 and have evolved alternative
mechanisms to compensate any deficiency of ATR recruitment caused by absence of
FANCM or FAAP24. However, it is still possible that the function of FANCM and FAAP24
in UV- and HU-induced ATR activation is not essential in the first place, since the RPA
accumulation was not affected by loss of FANCM or FAAP24 in these contexts (Huang et al.,
2010).
In response to ICL damage however, both replicative helicase and DNA polymerase
are stalled by the DNA lesions. Consequently, the accumulation of RPA coated ssDNA is
less efficient. My result (Fig 4.3) showed that defects in MMC-induced ATR activation is
manifested specifically by loss of FAAP24. Furthermore, I showed that the function of
FAAP24 in ICL-induced ATR activation is independent of its interaction with FANCM (Fig
4.5). Why FAAP24 is uniquely required for ICL-induced checkpoint activation is unclear.
Given the importance of ssDNA structures for ATR activation, the fact that FAAP24 has
high affinity towards ssDNA while FANCM prefers branched DNA structures (Ciccia et al.,
2007; Gari et al., 2008b) may be one explanation of selective requirement for FAAP24 in
ICL-induced activation of ATR-mediated DNA damage checkpoint. In addition, the intrinsic
ICL binding activity of FAAP24 also underscores the importance of FAAP24 in activating
ATR-mediated checkpoint in response to crosslinking agents (Huang et al., 2010). It is
plausible that the FANCM-independent ICL binding activity of FAAP24 is an important
alternative mechanism for enhanced recruitment of ATR-ATRIP kinase in the context of
insufficient RPA-ssDNA accumulation in response to ICL damage.
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CHAPTER V
FANCM Promotes Recombination-independent Repair of Interstrand Crosslinks

Introduction
In previous Chapters, I demonstrated that the FANCM-/-/FAAP24-/- double knockout
mutant was much more sensitive to DNA crosslinking agents than FANCM-/- and FAAP24-/single mutants, suggesting that FANCM and FAAP24 have cooperative as well as unique
functions in response to ICL damage. I also showed that FAAP24 has a major function in
activating ATR-mediated DNA damage checkpoint in response to ICL damage, which is
independent of FANCM. Lack of checkpoint activation defect in the FANCM-/- knockout
cells prompted me to explore checkpoint-independent function of FANCM in response to
ICL damage. One possibility is that FANCM may be involved in the actual removal of ICL
lesions.
In mammalian cells, ICLs are primarily repaired in S phase cells when the ICL
damage is encountered by DNA replication forks. This repair process involves multiple
coordinated

steps

including

ICL

unhooking,

translesion

synthesis,

homologous

recombination, and nucleotide excision repair (Deans and West, 2011). The function of
FANCM and FAAP24 in this pathway is likely tethered together for two reasons. First, a
functional FA pathway is required for the replication-coupled repair of ICL (Knipscheer et al.,
2009; Long et al., 2011). Second, the replication fork remodeling-stabilization activity in vivo
is likely achieved by the FANCM-FAAP24 heterodimer since they bind stalled fork
synergistically (Yan et al., 2010).
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There exists another pathway for ICL repair in mammalian cells that is not coupled
with DNA replication. This pathway mainly consists of ICL unhooking, translesion synthesis
and nucleotide excision repair (Deans and West, 2011; Wang et al., 2001). It is considered to
be a minor pathway that primarily operates in G1 phase. Since no DNA replication is
involved, the processing or unhooking of ICL will not lead to double strand break generation.
Therefore, homologous recombination mediated repair is not involved in this repair pathway.
Consequently, this recombination-independent ICL repair pathway tends to be error prone.
Whether FA and FA-associated proteins are involved in recombination-independent
ICL repair remains unclear. In this Chapter, I investigated the impact of FANCM, FAAP24
and FANCB loss on recombination-independent ICL repair efficiency, and I found that
FANCM, but not FAAP24 or the FA core complex component FANCB, is required for
efficient ICL removal through the recombination-independent repair pathway. I provide
further evidence demonstrating that FANCM functions to recruit NER factors and lesion
bypass factors to damage sites for efficient ICL repair. These functions rely on the
translocase activity of FANCM, which likely allows FANCM to detect ICL lesions and act to
create lesion accessibility for repair factors.
Materials and Methods
Cell culture
ERCC1+/+ and ERCC1-/- Chinese hamster ovary (CHO) cells were cultured in
Minimum Essential Medium (MEM) plus 10% FBS, and XPA-/- and XPA complemented
XPA-/- fibroblasts were cultured in MEM plus 15% FBS. All cells were grown in a
humidified 5% CO 2 -containing atmosphere at 37°C.
Antibodies
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FAAP100 antibody was described previously (Ling et al., 2007). Sources of
antibodies (that were not described in previous chapters) are as follows: anti-PCNA (P8825,
Sigma-Aldrich); anti-ERCC1 (MS-671-P0, Neomarker); anti-RPA (ab2175, Abcam); antiphospho-RPA Ser10 (MA1-26418, Thermo Scientific); anti-Rev1 (sc-48806X, Santa Cruz);
anti-XPA (MS-650-P1ABX, Neomarker).
Cell cycle analysis
To determine G1/S transition in response to DNA damage, cells were treated with
MMC for 6 or 16 hrs, pulse labeled with 10 µM BrdU for 30 min, harvested and fixed as
above. Fixed cells were resuspended in 2 N HCl containing 0.2 mg/ml pepsin and incubated
at 37 °C for 20 min, after which 0.1 M sodim tetraborate (pH 8.5) was added for
neutralization. Cells were then washed with 1% BSA/PBS containing 0.5% Tween 20,
incubated with Alexa Fluor 488-conjugated anti-BrdU (1:20 in 1% BSA/PBS containing
0.5% Tween 20) in the dark at room temperature for 30 min, and stained with propidium
iodide (PI) buffer (0.2 mg/ml RNase A and 5 µg/ml PI in PBS) in the dark at room
temperature for 30 min. Percentages of cells in G1, S and G2/M phases were quantified by
flow cytometry analysis.
Recombination-independent ICL repair assay
To assess recombination-independent ICL repair efficiency, the luciferase reporter
reactivation assay was performed as descried previously (Shen et al., 2009). Briefly, 1 ng of
reporter substrate with a transcription blocking ICL, or 1 ng of an undamaged control
reporter, was transfected into cells together with 50 ng β-galactosidase plasmid. The relative
ICL repair efficiencies were calculated as the percentage of luciferase activity of the
crosslinked reporter normalized to that of the undamaged reporter, after individual
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normalization against the β-galactosidase internal control. Experiments were performed with
duplicate transfections.
eChIP assay
eChIP assay was carried out according to protocols described earlier (Shen et al.,
2009; Wang and Li, 2011).
Results
FANCM is required for recombination-independent repair of ICLs
The convergence of the FA pathway and the breast cancer susceptibility pathway
strongly indicates that FA proteins play important roles in homologous recombination
mediated repair of ICLs. In mammalian cells, there exists another ICL repair mechanism
which is recombination-independent and error-prone (Deans and West, 2011; Wang et al.,
2001). Whether FA proteins are involved in the recombination-independent repair of ICLs
has not been well studied.
To determine whether FANCM and FAAP24 are required for recombinationindependent ICL repair, I examined the ICL repair efficiency in FANCM-/-, FAAP24-/- and
FANCM-/-/FAAP24-/- somatic knockout cell lines using a luciferase reporter assay previously
established by our group (Wang et al., 2001). Briefly, a single psoralen ICL was introduced
at a defined position between the CMV promoter and the luciferase coding region in the
reporter plasmid. Presence of this site-specific ICL blocks gene transcription and luciferase
expression, and repair of the ICL in vivo results in reactivation of lucidersase expression (Fig
5.1A). Due to unavailability of undamaged homologous sequences in chromosomal DNA,
removal of this psoralen ICL in vivo is expected to be achieved by recombinationindependent repair mechanisms. When the reporter plasmids were introduced into cells
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together with internal control vectors expressing beta-galactosidase, the recombinationindependent ICL repair efficiency can be quantified by normalizing luciferase activity
against beta-galactosidase activity.
As shown in Fig 5.1B, FANCM-/- and FANCM-/-/FAAP24-/- knockout cells showed
reduced recombination-independent ICL repair by ~30% compared with wild type HCT-116
cells, suggesting that FANCM is required for efficient removal of ICLs through the
recombination-independent repair pathway. In contrast, the ICL repair in FAAP24-/- and
FANCB- cells was as efficient as that in wild type cells, suggesting that the function of
FANCM in recombination-independent ICL repair is likely FAAP24- and FA core complexindependent.
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Fig. 5.1 FANCM promotes recombination-independent ICL repair.
(A) Schematics of the reporter reactivation-based recombinant-independent ICL repair assay.
Control and crosslinked reporter represent the unmodified and site-specifically crosslinked
plasmid substrates, respectively. CMV: CMV promoter.
(B) Recombination-independent ICL repair efficiencies in FANCM and FAAP24 mutant cell
lines. Error bars represent standard deviation of 6 independent experiments (* P < 0.05 vs.
wild type).

114

115

Reduced recombination-independent ICL repair leads to delayed G1/S transition
Recombination-independent ICL repair primarily operates during the G1/G0 phase of
cell cycle when the lesion is not encountered by DNA replication and when homologous
recombination mediated repair is dormant. Therefore, failure in efficient ICL removal
through the recombination-independent repair mechanism is expected to impact primarily
G1/G0 phase cells. Most likely, insufficient ICL repair will cause cell accumulation at G1/G0
phase or the G1/S boundary. To validate this prediction, I analyzed cell cycle progression in
FANCM-/-, FAAP24-/- and FANCM-/-/FAAP24-/- knockout cells that were exposed to MMC.
The cell cycle profile in untreated wild type cells and knockout cells were identical,
suggesting that loss of FANCM, FAAP24 or FANCB did not alter cell cycle progression in
unperturbed growth conditions (Fig 5.2). However, when exposed to MMC, there was a
prominent increase of G1/G0 phase cells in FANCM-/- and FANCM-/-/FAAP24-/- knockout
cells, but not in the FAAP24-/- or FANCB- mutants (Fig 5.2). These results suggest that
impaired recombination-independent ICL repair associated with FANCM loss leads to
delayed G1/S cell cycle transition.
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Fig. 5.2 Loss of FANCM leads to delayed G1/S cell cycle transition in response to MMC.
(A) Cells with indicated genotypes were exposed to 1000 ng/ml MMC for 16 hours and
pulse-labeled with BrdU before harvesting. Cell cycle distribution was determined by
bivariate flow cytometry with anti-BrdU and PI staining.
(B-C) Quantification of cell cycle distribution in cells with indicated genotypes exposed to
MMC (1000 ng/ml). Represented results of several independent experiments are shown.
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To further validate the impact of recombination-independent ICL repair on G1/S cell
cycle transition, I tested cell cycle progression in cells lacking ERCC1 or XPA, which were
shown to be defective in recombination-independent ICL repair (Wang et al., 2001; Zheng et
al., 2003). As shown in Fig 5.3, compared to wild type cells, ERCC1-/- CHO cells exhibited
significant increases in G1/G0 phase cells when treated with MMC. Similarly, compared
with XPA corrected cells, XPA-/- fibroblasts showed significant accumulation of G1/G0
phase cells when identically exposed to MMC (Fig 5.4). Collectively, these results suggest
that impaired recombination-independent ICL repair leads to blocked transition of cell cycle
form G1/G0 phase to S phase.
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Fig. 5.3 Loss of ERCC1 leads to delayed G1/S cell cycle transition in response to MMC.
(A) Cells with indicated genotypes were exposed to 1000 ng/ml MMC for 16 hours and
pulse-labeled with BrdU before harvesting. Cell cycle distribution was determined by
bivariate flow cytometry with anti-BrdU and PI staining.
(B) Quantification of cell cycle distribution in cells with indicated genotypes exposed to
MMC (1000 ng/ml). Represented results of several independent experiments are shown.
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Fig. 5.4 Loss of XPA leads to delayed G1/S cell cycle transition in response to MMC.
(A) Cells with indicated genotypes were exposed to 1000 ng/ml MMC for 16 hours and
pulse-labeled with BrdU before harvesting. Cell cycle distribution was determined by
bivariate flow cytometry with anti-BrdU and PI staining.
(B) Quantification of cell cycle distribution in cells with indicated genotypes exposed to
MMC (1000 ng/ml). Represented results of several independent experiments are shown.
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FANCM promotes PCNA monoubiquitination and lesion bypass factor recruitment
during recombination-independent ICL repair
Next I sought to investigate how FANCM functions to promote the recombinationindependent repair of ICL. A key step in this particular ICL repair pathway is PCNA
monoubiquitination. Ubiquitinated PCNA recruits the lesion bypass polymerase to replace
the normal replicative polymerase and to enable translesion DNA synthesis (Kelsall et al.,
2012; Shen et al., 2006). Therefore, I first examined whether the absence of FANCM will
affect PCNA monoubiquitination in response to MMC. To eliminate potential interference
from PCNA-monoubiquitination in response to replication fork stall, cells were grown to
over-confluency to maximally enrich for cells in G1/G0 phase, during which the
recombination-independent ICL repair is the predominant ICL removal mechanism. As
shown in Fig 5.5, loss of FANCM caused a significant reduction of PCNA
monoubiquitination in response to MMC, whereas cells lacking FAAP24 or FANCB
exhibited wild-type levels of PCNA monoubiquitination. These results indicate that FANCM,
but not FAAP24 or the FA core complex, functions in the recombination-independent repair
of ICLs.
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Fig. 5.5 Immunoblot of PCNA monoubiquitination in confluent FANCM and FAAP24
mutant cells exposed to MMC. Upper and lower bands represent monoubiquitinated and
native forms of PCNA respectively.
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To determine whether impaired PCNA monoubiquitination observed in cells lacking
FANCM leads to decreased recruitment of lesion bypass factors, I examined Rev1
recruitment in response to ICL damage, using the eChIP assay established by our group
(Shen et al., 2009). This assay (Fig 5.6A) allows protein recruitment at site-specific ICLs on
an episomal plasmid to be directly examined by chromatin immunoprecipitaion followed by
quantitative PCR (ChIP-QPCR). The plasmid substrate contains an Epstein-Barr virus (EBV)
replication origin (OriP), which allows its unidirectional replication only in the presence of
Epstein-Barr nuclear antigen 1 (EBNA1). I introduced the control substrate and the ICL
substrate in parallel into wild type HCT-116 and FANCM-/- cells that were both EBNA1negative, and measured Rev1 enrichment at the defined ICL site, which was reflective of in
vivo Rev1 recruitment during recombination-independent ICL repair. As shown in Fig 5.6B,
Rev1 was significantly enriched at the ICL sites in wild type cells. However, lack of
FANCM greatly impaired Rev1 recruitment to site-specific ICLs, suggesting that decreased
PCNA monoubiquitination resulted in compromised recruitment of lesion bypass factor.
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Fig. 5.6 Loss of FANCM impairs Rev1 recruitment at ICL sites.
(A) Schematics of the eChIP assay. Control and crosslinked substrate represent the
unmodified and site-specifically crosslinked plasmid substrates, respectively. EBV OriP:
EBV replication origin.
(B) eChIP assay for Rev1 recruitment to a site-specific ICL in wild type and FANCM-/mutant cells. Ctrl: unmodified substrate. XL: crosslinked substrate. Percentages of relative
enrichment were calculated by normalizing comparative concentration of each sample
against that of its input. Error bars represent stand deviation of triplicates. The asterisk (*)
denotes P < 0.01 vs. wild type.
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FANCM is required for the recruitment of nucleotide excision repair factors during
recombination-independent ICL repair
Reduced PCNA monoubiquitination in FANCM deficient cells may reflect
insufficient upstream incision of crosslinked DNA by the nucleotide excision repair (NER)
proteins, since the NER-mediated ICL unhooking creates a repair intermediate necessary for
the onset of PCNA monoubiquitination. I therefore investigated whether lack of FANCM
affects the recruitment of NER factors to ICL damage sites. To this end, I examined
recruitment of XPA and ERCC1 to site-specific ICLs using the eChIP assay. As shown in Fig
5.7, XPA and ERCC1 were significantly enriched at the defined ICL site in wild type cells.
In contrast, in FANCM-/- knockout cells, the recruitment of XPA and ERCC1 were
significantly reduced. These results suggest that FANCM promotes ICL unhooking by
facilitating localization of incision activities in the absence of DNA replication. Consistent
with its proficient ICL repair efficiency (Fig 5.1B), the FAAP24-/- mutant did not show visible
defect of ERCC1 recruitment (Fig 5.7B). This result further suggests that the function of
FANCM in recombination-independent ICL repair is independent of FAAP24.
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Fig. 5.7 Loss of FANCM impairs XPA and ERCC1 recruitment at ICL sites.
(A) eChIP assay for XPA recruitment to a site-specific ICL in wild type and FANCM-/-mutant
cells. Ctrl: unmodified substrate. XL: crosslinked substrate. Percentages of relative
enrichment were calculated by normalizing comparative concentration of each sample
against that of its input. Error bars represent stand deviation of triplicates. The asterisk (*)
denotes P < 0.01 vs. wild type.
(B) eChIP assay for ERCC1 recruitment to a site-specific ICL in wild type, FANCM-/- and
FAAP24-/- mutant cells. Ctrl: unmodified substrate. XL: crosslinked substrate. Percentages of
relative enrichment were calculated by normalizing comparative concentration of each
sample against that of its input. Error bars represent stand deviation of triplicates. The
asterisk (*) denotes P < 0.01 vs. wild type.
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The function of FANCM in recombination-independent ICL repair requires its
translocase activity
FANCM-FAAP24 displays structural resemblance with the XPF-ERCC1 and Mus81Eme1/2 structure-specific nucleases. It is possible that FANCM recruits ERCC1 and other
NER proteins through protein-protein interaction. However, when tested by Co-IP
experiments, FANCM was not found to interact with ERCC1, or other NER proteins
including XPA, XPC, XPD and XPG (data not shown). Therefore, the function of FANCM
in facilitating the localiztion of NER proteins is likely through mechanisms other than direct
protein recruitment.
FANCM possesses a DEAH helicase domain and associated translocase activity. This
allows FANCM to translocate on DNA. It is plausible that the FAAP24-independent
translocase activity functions in ICL damage recognition, or acts to create lesion access,
thereby allowing the recruitment of NER factors and other downstream repair proteins. To
test this premise, I stably complemented the FANCM-/- cells with a FANCM translocase
mutant (K117R) and examined its function in recombination-independent ICL repair. Wild
type FANCM complemented FANCM-/- cell lines were also established as controls (Fig
5.8A).
As shown in Fig 5.8B, while wild type FANCM protein rescued the ICL repair
deficiency of the FANCM-/- knockout cell line, the K117R translocase mutant complemented
FANCM-/- cells remained deficient in recombination-independent ICL repair. This result
strongly suggests that the translocase activity is important for FANCM to function in ICL
repair.
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Fig. 5.8 FANCM translocase activity is required for efficient recombination-independent ICL
repair.
(A) Immunoblot detecting expression of wild type FANCM and the K117R translocase
mutant in two independent stable clones.
(B) Recombination-independent ICL repair efficiencies in FANCM-/- cells complemented
with wild type or K117R FANCM. Error bars represent standard deviation of 6 independent
experiments (* P < 0.05 vs. wild type).
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To further understand the function of FANCM in ICL repair, I examined the K117R
translocase mutant for its ability to recruit NER and lesion bypass factors. As shown in Fig
5.9, recruitments of the lesion binding protein XPA and lesion incision protein ERCC1 were
significantly decreased in cells lacking the FANCM translocase activity. In addition, the
recruitment of lesion bypass factor Rev1 was also markedly reduced in the absence of the
FANCM translocase activity (Fig 5.10). Taken together, these results suggest that the
translocase activity of FANCM promotes the recruitment of multiple repair factors, and it is
therefore crucial for recombination-independent ICL repair.
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Fig. 5.9 FANCM translocase activity is required for XPA and ERCC1 recruitment at ICL
sites.
(A) eChIP assay for XPA recruitment to a site-specific ICL in FANCM-/- cells complemented
with wild type or K117R FANCM. Ctrl: unmodified substrate. XL: crosslinked substrate.
Percentages of relative enrichment were calculated by normalizing comparative
concentration of each sample against that of its input. Error bars represent stand deviation of
triplicates. The asterisk (*) denotes P < 0.01 vs. wild type complemented cells.
(B) eChIP assay for ERCC1 recruitment to a site-specific ICL in FANCM-/- cells
complemented with wild type or K117R FANCM. Ctrl: unmodified substrate. XL:
crosslinked substrate. Percentages of relative enrichment were calculated by normalizing
comparative concentration of each sample against that of its input. Error bars represent stand
deviation of triplicates. The asterisk (*) denotes P < 0.01 vs. wild type complemented cells.
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Fig. 5.10 eChIP assay for Rev1 recruitment to a site-specific ICL in FANCM-/- cells
complemented with wild type or K117R FANCM. Ctrl: unmodified substrate. XL:
crosslinked substrate. Percentages of relative enrichment were calculated by normalizing
comparative concentration of each sample against that of its input. Error bars represent stand
deviation of triplicates. The asterisk (*) denotes P < 0.01 vs. wild type complemented cells.
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The translocase activity of FANCM is dispensable for FA pathway activation
The fact that FAAP24 and FANCB are not required for the recombinationindependent repair of ICL (Fig 5.1B & Fig 5.7B) suggests that the function of FANCM in
this particular ICL repair pathway may be independent on its function in FA pathway
activation. To test this hypothesis, I examined the FA pathway function in the K117R
translocase mutant complemented FANCM-/- knockout cells.
As shown in Fig 5.11A, the K117R translocase mutant of FANCM was competent in
interacting with FA core complex components including FAAP100, FANCG and FANCL.
Therefore, the recruitment of FA core complex in response to DNA damage most likely does
not require the translocase activity of FANCM. Consistent with this notion, K117R
translocase mutant complemented FANCM-/- cells showed wild type levels of FANCD2
monoubiquitination (Fig 5.11B) and FANCD2 nuclear foci formation in response to MMC
(Fig 5.12). These results suggest that the translocase activity of FANCM is not required for
efficient activation of the FA pathway.
Previous studies have reported that the FANCM translocase activity contributes to
normal resistance to MMC but not FANCD2 monoubiquitination (Gari et al., 2008b; Xue et
al., 2008), indicating that FANCM had additional translocase-associated function outside the
FA pathway. This is consistent with my finding that FANCM promotes recombinationindependent ICL repair through its translocase activity.
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Fig. 5.11 The translocase activity of FANCM is not required for its interaction with FA core
complex and FANCD2 monoubiquitination.
(A) Co-immunoprecipitation detecting interactions between indicated FA core components
and wild type FANCM or K117R mutant FANCM.
(B) Immunoblot detecting MMC-induced monoubiquitination of FANCD2 in FANCM-/- cells
complemented with wild type or K117R FANCM. L and S represent monoubiquitinated and
native forms of FANCD2, respectively.
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Fig. 5.12 FANCM translocase activity is not required for FANCD2 nuclear foci formation.
(A) Formation of MMC-induced (500 ng/ml) FANCD2 nuclear foci in FANCM-/- cells
complemented with wild type or K117R FANCM.
(B) Quantification of FANCD2 nuclear foci formation in FANCM-/- cells complemented with
wild type or K117R FANCM. Data represent three independent experiments and error bars
depict standard deviation derived from 5 data sets.
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Discussion
The functional impacts of FA proteins on DNA damage response and ICL repair have
largely been studied in the context of DNA replication. In mammalian cells, there exists an
alternative recombination-independent mechanism for ICL repair which primarily operates in
the G1/G0 phase of cell cycle. However, it remains unclear whether FA proteins function in
the recombination-independent ICL repair. In this study, I found that FANCM, but not
FAAP24 or the FA core complex component FANCB, is required for efficient ICL repair
through the recombination-independent pathway. I also demonstrated that the function of
FANCM in recombination-independent ICL repair requires its tranlocase activity. My study
therefore uncovers a previously unappreciated role of FANCM in recombination-independent
ICL repair through its translocase activity.
Repair of ICL by this recombination-independent pathway involves a few major steps,
including ICL unhooking via lesion incision by nucleotide excision repair (NER)
endonucleases, PCNA-mediated polymerase switch, translesion synthesis across the lesion,
and lesion removal by NER factors (Shen et al., 2006). The data I presented here
demonstrated that FANCM deficiency leads to compromised ERCC1 recruitment to ICL
sites, reduced PCNA monoubiquitination, and impaired recruitment of lesion bypass factor
REV1. Therefore, it is very likely that FANCM functions at an early step to facilitate ICL
processing by endonucleases.
The recruitment of structural-specific endonuclease complex XPF/ERCC1 is less
likely to be through direct FANCM association, since the interactions among XPF family
members (XPF/ERCC1, Mus81/Eme1 or Eme2, FANCM/FAAP24) are quite specific (Ciccia
et al., 2007). Indeed, I did not detect any direct interaction between FANCM and ERCC1. In
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addition, FANCM was not found to interact with other NER factors including XPA, XPC,
XPD and XPG. Collectively, these results suggest that FANCM promotes the recruitment of
NER factors through a mechanism other than protein-protein interaction.
Since FANCM possesses ATP-dependent DNA translocase activity, it may slide on
DNA and act as a DNA damage sensor that facilitates the recruitment of XPF/ERCC1 and
other repair components upon lesion recognition. Consistent with this model, I found that
FANCM-/- cells carrying a FANCM K117R translocase mutant showed defective recruitment
of repair factors including XPA, ERCC1 and Rev1, and consequently displayed impaired
recombination-independent ICL repair.
How FANCM promotes the recruitment of downstream repair components upon
DNA damage recognition remains unclear. FANCM translocase activity may function in
creating lesion accessibility for incision activities and subsequent repair factors. NER
incision requires a significant span of nucleosome-free duplex DNA (Hara et al., 2000). A
feasible role for FANCM is therefore to release DNA flanking the ICL lesion from
nucleosome contact via its translocation actions, thus allow access of NER factors.
Consistently, recent observations by Kelsall et al show that FANCM participates in the NER
process (Kelsall et al., 2012). Alternatively, FANCM may promote the relaxation of
chromatin structures and exposure of DNA flanking the ICL lesions. DNA is highly
compacted in G1/G0 phase, and chromatin remodeling processes are likely required for
efficient ICL repair through the recombination-independent pathway. It remains a possibility
that FANCM recruits certain chromatin remodeling factors upon ICL recognition, and
subsequent DNA exposure will allow better access of NER factors, particularly the
XPF/ERCC1 endonuclease complex which mediates the ICL unhooking.
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CHAPTER VI
Conclusions and Future Directions

Conclusions
The purpose of this study was to generate human genetic models for FANCM and
FAAP24, and to systematically investigate the functions of FANCM and FAAP24 in DNA
damage response and repair.
I found that while FANCM-/- and FAAP24-/- single mutants displayed readily
detectable hypersensitivity to ICL damage, FANCM-/-/FAAP24-/- double-knockout cells
exhibited much more severe hypersensitivity. Consistently, I found that MMC-induced
chromosomal breakage occurred at a higher frequency in FANCM-/-/FAAP24-/- double mutant
than in either single mutant. These results suggest that FANCM and FAAP24 are not fully
epistatic in cellular response to ICL damage, and prompted me to explore cooperative as well
as unique functions of FANCM and FAAP24 in DNA damage response.
I found that by facilitating chromatin loading of the FA core complex, FANCM and
FAAP24 promote FANCD2 monoubiquitination and FANCD2 nuclear foci formation in
response to ICL damage, which are central events in FA pathway activation. Notably,
FANCM-/-/FAAP24-/-

double

mutant

showed

no

further

decrease

in

FANCD2

monoubiquitination compared with either single mutant, suggesting that FANCM and
FAAP24 work in concert to promote FA pathway activation. In addition, I found that
FANCM-/-, FAAP24-/- and FANCM-/-/FAAP24-/- cells displayed comparable amount of tetraradial chromosomes and sister chromatid exchanges in response to ICL damage, suggesting
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that FANCM and FAAP24 cooperatively suppress crossover recombination during ICL
repair.
Besides their cooperative functions, I discovered unique functions of FANCM and
FAAP24 in DNA damage response that is independent of the FA pathway. I found that
FAAP24 but not FANCM promotes ATR-mediated checkpoint activation specifically in
response to ICL damage. A V198A FAAP24 mutant which failed to interact with FANCM
could restore the ATR-mediated checkpoint activation and partially rescue ICL
hypersensitivity of FAAP24-/- cells, further indicating a FANCM-independent function of
FAAP24 in DNA damage checkpoint activation. Conversely, I found that FANCM but not
FAAP24 promotes recombination-independent repair of ICL during G1/G0 phase, leading to
delayed G1/S transition. Mechanistically, I established that FANCM exerts its function in
recombination-independent ICL repair through its FAAP24-independent translocase activity.
In the absence of FANCM translocase activity, the recruitments of NER factors including
XPF/ERCC1 which are crucial for ICL incision, as well as the Rev1-containing lesion bypass
complex that is important for translesion DNA synthesis, were greatly impaired. In addition,
the FANCM translocase mutant was capable of supporting FA core complex interaction and
FANCD2 monoubiquitination, further suggesting that FANCM functions independently of
the FA pathway to promote efficient ICL repair through the recombination-independent
mechanism.
Collectively, my studies defined that FANCM and FAAP24 maintain genomic
stability via intercalated mechanisms - facilitating FA pathway activation, activating DNA
damage checkpoint, and promoting recombination-independent ICL repair. These findings
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reveal novel mechanistic insights into how genome integrity is both coordinately and
independently protected by FANCM and FAAP24.
Working Model
Based on the above findings, I propose a model that depicts refined understanding of
FANCM and FAAP24 in the maintenance of genomic stability (Fig 6.1). FANCM and
FAAP24 protect cells from crosslinking damage via intercalated mechanisms - facilitating
FA pathway activation, suppressing crossover recombination, activating ATR-mediated
DNA damage checkpoint, and promoting recombination-independent ICL repair. When cells
are individually devoid of FANCM or FAAP24, the FA pathway activation is partially
disabled and the SCE phenotype manifests, accompanied by impaired recombinationindependent ICL repair or DNA damage checkpoint control, respectively, resulting in
intermediate sensitivities to ICL damage. When FANCM and FAAP24 are both absent, the
compounded defects in FA pathway activation, DNA damage checkpoint control and
recombination-independent ICL repair is expected to cause significantly increased sensitivity.

151

Fig. 6.1 Coordinated and non-epistatic functions of FANCM and FAAP24 in response to
DNA interstrand crosslink damage.
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Future Studies
Structure-function analysis of FAAP24
As was described in Chapter IV, I found that the function of FAAP24 in ICL-induced
ATR-mediated checkpoint activation was independent of its interaction with FANCM (Fig
4.5). It would be interesting to determine whether and how the FANCM-associated FA
pathway activation function and the FANCM-independent checkpoint activation function of
FAAP24 are segregated. To this end, I initiated a structure-function analysis of FAAP24.
FAAP24 contains an ERCC4 domain and an (HhH) 2 domain. The conserved
ERKXXXD motif in the ERCC4 domain is degenerated to LYVTEAD in FAAP24, and
consequently FAAP24 was not found to possess any nuclease activity. However, whether the
degenerated ERCC4 domain remains important for FAAP24 function is not clear. (HhH) 2
motifs are present in many DNA-binding proteins, and are found to be important for
dimerization of XPF-ERCC1. Whether the (HhH) 2 domain of FAAP24 mediates FANCM
interaction and confers DNA binding activities needs to be determined.
I first generated a series of FAAP24 truncation mutants (Fig 6.2A) to determine
which domain of FAAP24 was responsible for FANCM interaction. As shown by Co-IP
experiments (Fig 6.2B), the (HhH) 2 domain of FAAP24 is required for its interaction with
FANCM. Importantly, the (HhH) 2 domain was also required for its in vitro ssDNA binding
activity (Biochemical experiments were performed by our collaborators and data were not
shown here). These results suggest that the C-terminal (HhH) 2 domain of FAAP24 is
important for both dimerization with FANCM and DNA binding.
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Fig. 6.2 The (HhH) 2 domain of FAAP24 is required for FANCM interaction.
(A) Schematics of FAAP24 truncation mutants. The conserved ERKXXXD motif in ERCC4like domain critical for nuclease activity is degenerated to ILYVTEAD, as indicated in pink.
The HhH motifs are indicated in green.
(B) Co-immunoprecipitation of Myc-tagged full length FAAP24 and the truncation mutants
with FANCM.
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To better understand the function of the (HhH) 2 domain of FAAP24, we collaborated
with structural biologists and determined the C-terminal structure of FAAP24 (data not
shown). I also generated a series of FAAP24 point mutants according to insights from
sequence alignment (Fig 6.3) and structural data. We tested the FAAP24 mutants for
FANCM interaction and DNA binding activity. I co-expressed the FAAP24 mutants along
with wild type FANCM in HEK293T cells, and examined their interaction. As shown in Fig
6.4, replacement of the GVG, LLL, VVG and FF residues of FAAP24 resulted in severe
disruption of its FANCM interaction. In vitro DNA binding assay performed by our
collaborators showed that disruption of K171 and K173 residues significantly reduced the
DNA binding activity of FAAP24 (data not shown).
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Fig. 6.3 Sequence alignment of the core ERCC4-like domain and (HhH) 2 domain across
species. Locations of the degenerated ERKXXXD motif in ERCC4-like domain critical for
nuclease activity and the conserved HhH motifs are indicated in blue. Mutation sites are
indicated in red.
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Fig. 6.4 Co-immunoprecipitation of Myc-tagged wild type FAAP24 and point mutants with
FANCM.
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To allow in vivo functional studies, I introduced the FAAP24 mutants into the
FAAP24-/- cells and generated a series of stable cell lines each carrying a unique FAAP24
mutation. Co-IP experiment using endogenous proteins confirmed that the GVG, LLL, VVG
and FF residues are important for FAAP24 to dimerize with FANCM (Fig 6.5). I also tested
the in vivo DNA binding activity of FAAP24 mutants by examining their chromatin
association. As shown in Fig 6.6, chromatin fractionation experiments confirmed that the
K171 and K173 residues are crucial for the DNA binding activity of FAAP24.
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Fig. 6.5 Co-immunoprecipitation of FAAP24 with FANCM in FAAP24-/- cells stably
expressing Myc-tagged wild type FAAP24 and point mutants.
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Fig. 6.6 Chromatin association of FAAP24 in FAAP24-/- cells stably expressing Myc-tagged
wild type FAAP24 and point mutants.
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Future studies will be carried out to further understand how the FANCM interaction
and DNA binding activity of FAAP24 contribute to ICL resistance and genomic stability
maintenance. To this end, I will examine the stable cell lines carrying various FAAP24
mutations for their MMC sensitivity, chromosomal stability, FA pathway activation, SCE
formation, and ATR-mediated checkpoint signaling. In addition, efforts will be taken to work
with collaborators to determine the co-crystal structure of full length FAAP24 bound with
FANCM C-terminal domain. Attempts will be made to include DNA molecules in the
structural work. These studies are anticipated to provide additional valuable insights into the
FAAP24 function on both structural and molecular/cellular levels.
Further investigation of the FANCM function in recombination-independent ICL
repair
I demonstrated in Chapter V that the translocase activity of FANCM is important for
its function in recombination-independent ICL repair (Fig 5.8B). How this DNA interacting
activity allows FANCM to promote efficient repair of ICL through the recombinationindependent pathway warrants further investigation. In the absence of FANCM translocase
activity, recruitment of NER factors ERCC1 and XPA as well as lesion bypass factor Rev1
was severely impaired (Fig 5.9 & Fig 5.10). These results indicate the possibility that
FANCM acts as an ICL damage sensor, and upon lesion detection it functions to create lesion
accessibility to allow the recruitment of repair factors. Since in G1/G0 phase the highly
packed chromatin structure presents obstacles for DNA access, it is likely that FANCM alters
the chromatin/DNA structure, directly or otherwise, to allow efficient recruitment of other
repair proteins.
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Interestingly, tandem affinity purification of FANCM identified that RuvbL1 and
RuvbL2, two integral components of the INO80 chromatin remodeling complex, strongly
associate with FANCM (Fig 6.7). Co-immunoprecipitation experiment using tagged proteins
verified that FANCM, but not FAAP24, interacts with RuvbL1 and RuvbL2 (Figs 6.8A&B).
This specific interaction was also verified by Co-IP of endogenous proteins (Fig 6.8C). Since
RuvbL1 and RuvbL2 belong to the INO80 chromatin remodeling complex, it is likely that
FANCM recruits the INO80 complex to remodel chromatin/DNA structure and therefore
allows access of ICL repair proteins.
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Fig. 6.7 IP-mass spec analysis of FANCM-interacting proteins via tandem affinity
purification. Numbers of peptides recovered from mass spectrometry analysis are presented.
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Fig. 6.8 FANCM but not FAAP24 interacts with RuvbL1 and RuvbL2.
(A) Co-immunoprecipition of Flag-FANCM with Myc-RuvbL1 or Myc-RuvbL2 in
HEK293T cells.
(B) Co-immunoprecipition of Myc-FAAP24 with HA-RuvbL1 or HA-RuvbL2 in HEK 293T
cells.
(C) Immunoprecipitation of endogenous RuvbL1 or RuvbL2 and immunoblot with antibodies
against FANCM, FAAP24 and Arp5.
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To determine whether RuvbL1 and RuvbL2 indeed act in the recombinationindependent ICL repair pathway, I established RuvbL1- and RuvbL2- shRNA stable
knockdown cell lines (Fig 6.9A) to study their functional outcome in ICL repair. As shown in
Fig 6.9B, lack of RuvbL1 or RuvbL2 rendered cells unable to efficiently remove ICL in a
recombination-independent manner. In addition, loss of RuvbL1 or RuvbL2 significantly
impaired the recruitment of ERCC1 to ICL sites (Fig 6.10).
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Fig. 6.9 RuvbL1 and RuvbL2 are required for recombination-independent ICL repair.
(A) Immunoblotting of RuvbL1 and RuvbL2 in HCT-116 cell clones stably transfected with
constructs expressing control shRNA (siCon), RuvbL1 shRNA (siRuvbL1), or RuvbL2
shRNA (siRuvbL2).
(B) ICL repair efficiencies in RuvbL1- and RuvbL2- knockdown cells. Error bars represent
standard deviation of 6 independent experiments (* P < 0.05 vs. wild type).
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Fig. 6.10 eChIP assay for ERCC1 recruitment to a site-specific ICL in RuvbL1- and
RuvbL2-knockdown cells. Ctrl: unmodified substrate. XL: crosslinked substrate. Percentages
of relative enrichment were calculated by normalizing comparative concentration of each
sample against that of its input. Error bars represent stand deviation of triplicates. The
asterisks (*) denote P < 0.01 vs. Ctrl ShRNA.
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While largely preliminary, these results strongly indicate that FANCM recruits
chromatin remodeling activities upon ICL lesion detection, which will create DNA
accessibility to allow recruitment of NER factors to initiate the ICL repair. Future studies
will be conducted to provide further evidences to substantiate such a promising working
model. Specifically, the following experiment will be performed: 1) to test whether
RuvbL1/2 are indeed recruited to ICL sites using the eChIP assay, and to examine whether
FANCM loss impairs the RuvbL1/2 recruitment; 2) to generate FANCM mutant(s) defective
for RuvbL1/2 interaction, and to test whether such mutant(s) could restore ERCC1
recruitment and ICL repair deficiency of FANCM-/- cells; 3) to investigate whether other
components of the INO80 complex are also involved in the recombination-independent
repair of ICL. Collectively, these results will potentially uncover novel functions of FANCM
and the INO80 complex in ICL repair.
Role of FANCM and FAAP24 in tumorigenesis
Since the knockout models I generated are on the HCT-116 cell platform, a further
functional investigation of FANCM and FAAP24 in genomic stability maintenance can be
achieved by examining their impact on tumorigenesis. To this end, I will use xenograft
models to study the tumorigenicity of FANCM and FAAP24 knockout cells along with wild
type HCT-116 cells. While a short term assay of tumor formation can be potentially affected
by the impact of FANCM and/or FAAP24 loss on cell proliferation and/or survival, it may
still provide valuable information in terms of the roles of FANCM and FAAP24 in tumor
development.
The FA pathway is important for ICL repair. Therefore, platinum based therapeutics
will be another emphasis in this study. Whether loss of FANCM and FAAP24 affects the
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sensitivity of tumor cells to platinum treatment is of clinical interest. If dysfunction of
FANCM or FAAP24 leads to increased response rate of the colon cancer cells to platinum
treatment, two implications will be obtained. First, although FANCM and FAAP24 mutations
have not been identified in FA patients, minor functional alterations of FANCM and
FAAP24 may be possible in colon cancer patients. In these patients, platinum based
chemotherapy may be emphasized. Second, small molecule inhibitors against FANCM and
FAAP24 will then be of clinical value in colon cancer treatment.
Given the roles of FANCM and FAAP24 in maintaining genome stability, it would
also be interesting to ask whether loss of FANCM and FAAP24 will affect the genomic
stability of cancer cells during tumor development. To this end, a long term follow up of
xenograft tumors will be carried out. By dissecting tumors at later stages during development
and looking for secondary genetic changes in the cells, new information of FANCM and
FAAP24 function in genomic stability maintenance may be discovered.

In summary, my current and extending studies provide novel mechanistic insights
into how FANCM and FAAP24 maintain genomic stability through cooperative as well as
unique functions.
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